<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Genet Genomics</journal-id><journal-title-group><journal-title>Molecular Genetics and Genomics </journal-title></journal-title-group><issn pub-type="ppub">1617-4615</issn><issn pub-type="epub">1617-4623</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">523</article-id><article-id pub-id-type="doi">10.1007/s00438-010-0523-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>The YEATS domain of Taf14 in <italic>Saccharomyces cerevisiae</italic> has a negative impact on cell growth</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Schulze</surname><given-names>Julia M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Kane</surname><given-names>Caroline M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Ruiz-Manzano</surname><given-names>Ana</given-names></name><address><phone>+1-314-3624821</phone><fax>+1-314-3627183</fax><email>ruizmanzanoa@biochem.wustl.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label>Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720-3202 USA </aff><aff id="Aff2"><label>2</label>Centre for Molecular Medicine and Therapeutics, University of British Columbia, 950 West 28th avenue, Vancouver, V5Z 4H4 Canada </aff><aff id="Aff3"><label>3</label>Department of Biochemistry, Washington University School of Medicine, 251 McDonnell Science Building, Saint Louis, MO 63110 USA </aff></contrib-group><author-notes><fn fn-type="com"><p>Communicated by M. Collart.</p></fn></author-notes><pub-date pub-type="epub"><day>24</day><month>2</month><year>2010</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>2</month><year>2010</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2010</year></pub-date><volume>283</volume><issue>4</issue><fpage>365</fpage><lpage>380</lpage><history><date date-type="received"><day>26</day><month>8</month><year>2009</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2010</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2010</copyright-statement></permissions><abstract xml:lang="en"><p>The role of a highly conserved YEATS protein motif is explored in the context of the Taf14 protein of <italic>Saccharomyces cerevisiae</italic>. In <italic>S. cerevisiae</italic>, Taf14 is a protein physically associated with many critical multisubunit complexes including the general transcription factors TFIID and TFIIF, the chromatin remodeling complexes SWI/SNF, Ino80 and RSC, Mediator and the histone modification enzyme NuA3. Taf14 is a member of the YEATS superfamily, conserved from bacteria to eukaryotes and thought to have a transcription stimulatory activity. However, besides its ubiquitous presence and its links with transcription, little is known about Taf14&#x02019;s role in the nucleus. We use structure&#x02013;function and mutational analysis to study the function of Taf14 and its well conserved N-terminal YEATS domain. We show here that the YEATS domain is not necessary for Taf14&#x02019;s association with these transcription and chromatin remodeling complexes, and that its presence in these complexes is dependent only on its C-terminal domain. Our results also indicate that Taf14&#x02019;s YEATS domain is not necessary for complementing the synthetic lethality between <italic>TAF14</italic> and the general transcription factor TFIIS (encoded by <italic>DST1</italic>). Furthermore, we present evidence that the YEATS domain of Taf14 has a negative impact on cell growth: its absence enables cells to grow better than wild-type cells under stress conditions, like the microtubule destabilizing drug benomyl. Moreover, cells expressing solely the YEATS domain grow worser than cells expressing any other Taf14 construct tested, including the deletion mutant. Thus, this highly conserved domain should be considered part of a negative regulatory loop in cell growth.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1007/s00438-010-0523-x) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>YEATS domain</kwd><kwd>TFIIS</kwd><kwd>Chromatin remodeling complex</kwd><kwd>Cell cycle</kwd><kwd>Microtubules</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag 2010</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>RNA polymerase II transcription is a tightly regulated process in which the chromatin near the gene to be transcribed is re-organized and remodeled, followed by the formation of the transcription pre-initiation complex and the processes of initiation, elongation and termination. Different multi-protein complexes are involved in these processes for regulation under normal or stress conditions. A similar phenomenon of complex regulation occurs during cell cycle progression where many changes take place including modulation of the cytoskeleton (Sawin and Tran <xref ref-type="bibr" rid="CR60">2006</xref>). Taf14 is one of the few proteins thought to play a role in all of these vital processes but its specific role is still unknown, and it is the focus of this work.</p><p><italic>TAF14</italic> was first identified (as <italic>ANC1</italic>) in a screen for mutations that enhance defects caused by a mutation in the actin gene (Welch et al. <xref ref-type="bibr" rid="CR75">1993</xref>). Cells devoid of Taf14 are viable but thermo- and osmo-sensitive (Henry et al. <xref ref-type="bibr" rid="CR30">1994</xref>) have defects in actin organization (Welch et al. <xref ref-type="bibr" rid="CR75">1993</xref>), and aberrant morphology and cytoskeletal defects (Henry et al. <xref ref-type="bibr" rid="CR30">1994</xref>). Additionally, Taf14 is physically associated with a variety of transcription and chromatin remodeling complexes (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a). It is present in, at least, three different ATP-dependent chromatin remodeling complexes: Swi/Snf, which possesses DNA-stimulated ATPase activity and activates transcription by helping transcription factors access their binding sites (Cairns et al. <xref ref-type="bibr" rid="CR5">1996</xref>; Sudarsanam and Winston <xref ref-type="bibr" rid="CR68">2000</xref>; Dechassa et al. <xref ref-type="bibr" rid="CR14">2008</xref>); Ino80, which has helicase activity and is involved in transcription, replication and repair (Shen et al. <xref ref-type="bibr" rid="CR63">2003a</xref>, <xref ref-type="bibr" rid="CR64">b</xref>; Conaway and Conaway <xref ref-type="bibr" rid="CR8">2009</xref>); and RSC, essential for cell cycle progression (Du et al. <xref ref-type="bibr" rid="CR15">1998</xref>; Eberharter et al. <xref ref-type="bibr" rid="CR16">1998</xref>), and known for repositioning and ejecting nucleosomes from active sites (Parnell et al. <xref ref-type="bibr" rid="CR55">2008</xref>). Taf14 also has been found in the histone&#x02013;acetyltransferase complex, NuA3 (John et al. <xref ref-type="bibr" rid="CR33">2000</xref>; Kabani et al. <xref ref-type="bibr" rid="CR34">2005</xref>) that stimulates transcription or replication elongation through nucleosomes by providing a coupled acetyltransferase activity (John et al. <xref ref-type="bibr" rid="CR33">2000</xref>). All of these complexes help transcriptional activators bind to occluded chromatin sites by perturbing histone&#x02013;DNA contacts or by covalently modifying histones (Clark-Adams et al. <xref ref-type="bibr" rid="CR6">1988</xref>; Imbalzano et al. <xref ref-type="bibr" rid="CR32">1994</xref>; Steger et al. <xref ref-type="bibr" rid="CR67">1998</xref>; Shen et al. <xref ref-type="bibr" rid="CR62">2000</xref>; Neely and Workman <xref ref-type="bibr" rid="CR52">2002</xref>; Cairns <xref ref-type="bibr" rid="CR4">2005</xref>). Roles for these complexes were first identified in transcriptional regulation (Kingston and Narlikar <xref ref-type="bibr" rid="CR38">1999</xref>; Davie and Kane <xref ref-type="bibr" rid="CR13">2000</xref>; Narlikar et al. <xref ref-type="bibr" rid="CR51">2002</xref>), but it has recently been shown that they also play diverse and complex roles in the DNA damage response (for review (Costelloe et al. <xref ref-type="bibr" rid="CR11">2006</xref>; Park et al. <xref ref-type="bibr" rid="CR54">2009</xref>)).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p><bold>a</bold> Seven nuclear complexes that contain or bind Taf14. The sizes are not to scale. The names of the proteins tagged in this study from each of the complexes are shown. <bold>b</bold> Truncated versions of Taf14 used in this study: <italic>TAF14, taf14[YEATS]</italic> (amino acids 6&#x02013;113), <italic>taf14[CT]</italic> (amino acids 113&#x02013;244), and <italic>taf14[-NT]</italic> (amino acids 61&#x02013;244). <bold>c</bold> Expression of the different Taf14 constructs. Equal amounts of cell extract were resolved on a 10% SDS-Laemmli protein gel and transferred to a nitrocellulose membrane for western blotting. Taf14 proteins were detected with Polyclonal Taf14 antibody. <italic>Left panel</italic><italic>taf14&#x00394;</italic> strain (CMKy70) containing plasmids expressing Taf14 constructs under its natural promoter. The YEATS fragment (<italic>Y</italic> second line) is practically not detected. Empty plasmid was used as negative control, PGK protein as loading control. <italic>Right panel</italic><italic>taf14&#x00394;</italic> strain (CMKy70) containing high copy plasmids expressing Tap-tagged Taf14 constructs under the PGK promoter. Empty pVV233 vector (TAP tag alone) was used as the negative control. The TAP tag is visible with the Taf14 antibody because it contains Protein A, recognized by IgG&#x02019;s in every polyclonal antibody. H+ vacuolar ATPase was used as loading control</p></caption><graphic xlink:href="438_2010_523_Fig1_HTML" id="MO1"/></fig></p><p>Taf14 is also a subunit of the yeast transcription factors TFIID (Poon et al. <xref ref-type="bibr" rid="CR56">1995</xref>) and TFIIF (Henry et al. <xref ref-type="bibr" rid="CR30">1994</xref>; Cairns et al. <xref ref-type="bibr" rid="CR5">1996</xref>) and seems to interact with TFIIB (Kimura and Ishihama <xref ref-type="bibr" rid="CR37">2004</xref>). TFIID recognizes the TATA box or other promoter elements and enables the binding of TFIIB and TFIIA. It is also known to modify histones (Mizzen et al. <xref ref-type="bibr" rid="CR48">1996</xref>; Cler et al. <xref ref-type="bibr" rid="CR7">2009</xref>). TFIIF assists the recruitment of RNA polymerase II, TFIIE and TFIIH into the pre-initiation complex (Buratowski et al. <xref ref-type="bibr" rid="CR3">1989</xref>; Flores et al. <xref ref-type="bibr" rid="CR22">1991</xref>, <xref ref-type="bibr" rid="CR23">1992</xref>; Henry et al. <xref ref-type="bibr" rid="CR30">1994</xref>). It is also involved in start site selection (Robert et al. <xref ref-type="bibr" rid="CR58">1998</xref>; Majovski et al. <xref ref-type="bibr" rid="CR45">2005</xref>; Khaperskyy et al. <xref ref-type="bibr" rid="CR35">2008</xref>) and elongation (Robert et al. <xref ref-type="bibr" rid="CR58">1998</xref>; Conaway et al. <xref ref-type="bibr" rid="CR9">2000</xref>; Zhang et al. <xref ref-type="bibr" rid="CR78">2005</xref>). Although a direct interaction has not always been detected (Kabani et al. <xref ref-type="bibr" rid="CR34">2005</xref>), Taf14 has also been suggested as a component of the transcriptional activator Mediator (Kim et al. <xref ref-type="bibr" rid="CR36">1994</xref>; Erlich et al. <xref ref-type="bibr" rid="CR17">2008</xref>), a global regulator important in recruiting of the transcription machinery and modulating RNA polymerase II activity after the alteration of the chromatin template by remodelers (Myers and Kornberg <xref ref-type="bibr" rid="CR50">2000</xref>; Baek et al. <xref ref-type="bibr" rid="CR2">2006</xref>; He et al. <xref ref-type="bibr" rid="CR29">2008</xref>). Supporting a role for Taf14 in initiation, in the <italic>ADH1</italic> gene (Krogan et al. <xref ref-type="bibr" rid="CR40">2002</xref>) and the <italic>GAL1</italic> gene (Kabani et al. <xref ref-type="bibr" rid="CR34">2005</xref>), Taf14 is recruited to the promoter region and not to the coding region, suggesting that Taf14 may be involved in the assembly of the RNA polymerase II pre-initiation complex. This recruitment is likely due to its presence in TFIID and TFIIF, but Taf14 also could have been recruited to that region through its association with the chromatin remodeling complexes described above.</p><p>In addition to the roles of Taf14 in chromatin remodeling and transcription initiation, in <italic>Saccharomyces cerevisiae</italic> there is a strong genetic interaction between Taf14 and the transcription elongation factor TFIIS (Fish et al. <xref ref-type="bibr" rid="CR21">2006</xref>). TFIIS stimulates RNA polymerase II during elongation to recover from an arrested state by inducing the polymerase to cleave its nascent transcript, thus realigning the new RNA 3&#x02032; end in the active site (Fish and Kane <xref ref-type="bibr" rid="CR20">2002</xref>; Ghavi-Helm et al. <xref ref-type="bibr" rid="CR25">2008</xref>). Neither TFIIS nor Taf14 is essential, but the double mutant results in synthetic lethality (Davie and Kane <xref ref-type="bibr" rid="CR13">2000</xref>; Fish et al. <xref ref-type="bibr" rid="CR21">2006</xref>). These two proteins are not functionally redundant, but have a functional interaction within a cellular process, most likely during transcriptional elongation and in concert with TFIIF (Fish et al. <xref ref-type="bibr" rid="CR21">2006</xref>). Taf14 (as well as proteins Gal1, Sua7, Rts1 or Tys1) has additionally been reported as a strong suppressor of the genetic interaction between <italic>DST1</italic> (the gene encoding for TFIIS) and SOH1 (when overexpressed) (Malagon et al. <xref ref-type="bibr" rid="CR46">2004</xref>). <italic>SOH1</italic> is a member of Mediator and, in Saccharomyces, is synthetically lethal with mutations in genes encoding subunits of the RNA polymerase II, TFIIB (Fan et al. <xref ref-type="bibr" rid="CR18">1996</xref>) and the histone H3 methyl transferase factor Set2 (Krogan et al. <xref ref-type="bibr" rid="CR41">2003</xref>). Taf14 is also one of the 5% of intron containing genes in yeast and, surprisingly, splicing of its intron is necessary to suppress a temperature-sensitive cell cycle arrest of <italic>cdc40&#x00394;</italic> cells (Dahan and Kupiec <xref ref-type="bibr" rid="CR12">2004</xref>).</p><p>Taf14 contains a highly conserved YEATS domain at its N-terminus and along with Yaf9 and Sas5 comprises the YEATS domain family in yeast. The name for this domain derives from the first discovered proteins containing the domain (Yaf9, ENL, AF9, Taf14, Sas5) (Harborth et al. <xref ref-type="bibr" rid="CR28">2000</xref>). Its function has not yet been described, but it is thought to be implicated in regulating transcription and chromatin remodeling (Schulze et al. <xref ref-type="bibr" rid="CR61">2009</xref>). This domain is found in many eukaryotic species as diverse as <italic>Arabidopsis</italic>, <italic>Drosophila</italic>, <italic>Caenorhabditis elegans,</italic> yeast and human. ENL, AF-9 (Corral et al. <xref ref-type="bibr" rid="CR10">1996</xref>) and Gas41 (Fischer et al. <xref ref-type="bibr" rid="CR19">1997</xref>) are the most extensively studied human proteins in this group. These three proteins are directly implicated in leukemias and gliomas whether by fusion of their non-YEATS domain to a protein called MLL in the case of ENL and AF-9 (Adler et al. <xref ref-type="bibr" rid="CR1">1999</xref>) or by amplification of its expression in the case of Gas41 (Munnia et al. <xref ref-type="bibr" rid="CR49">2001</xref>; Park and Roeder <xref ref-type="bibr" rid="CR53">2006</xref>). As mentioned above, the Taf14 YEATS domain presents striking homology with two other yeast nuclear proteins, Yaf9 and Sas5. Yaf9 is the ortholog of human Gas41, and is a component of the NuA4 HAT complex and the SWR1 complex, which deposits the histone variant H2A.Z (Le Masson et al. <xref ref-type="bibr" rid="CR44">2003</xref>; Zhang et al. <xref ref-type="bibr" rid="CR77">2004</xref>). Sas5 is a component of the SAS complex involved in chromatin silencing by acetylating free histones (Sutton et al. <xref ref-type="bibr" rid="CR69">2003</xref>; Shia et al. <xref ref-type="bibr" rid="CR65">2005</xref>).</p><p>Here, we present the first evidence that the YEATS domain of Taf14 exerts a negative effect on cell growth, and deletion of the YEATS domain results in a growth advantage under certain stress conditions. We further show that the C-terminus but not the YEATS domain of Taf14 is necessary and sufficient for the rescue of the synthetic lethality with TFIIS. Moreover, the C-terminus is also sufficient for association of Taf14 with the complexes involved in transcription and chromatin remodeling described above, revealing that the YEATS domain is not required for interaction with these complexes. These results suggest that, rather than a structural role, the YEATS domain has a regulatory function, possibly coordinating the transcription and replication processes during the cell cycle.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Plasmids, strains, genetic methods and media</title><p>The <italic>S. cerevisiae</italic> strains and plasmids used in this study are listed in Tables&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>. Taf14 point mutations were generated based on oligonucleotide-directed mutagenesis (Kunkel et al. <xref ref-type="bibr" rid="CR42">1987</xref>) using the &#x0201c;Quick Change&#x0201d; mutagenesis strategy, as directed by the manufacturer (Stratagene). <italic>Escherichia coli</italic> calcium-manganese-based transformations were used with the Top10 <italic>E. coli</italic> strain. Yeast cells were transformed using lithium acetate (Gietz et al. <xref ref-type="bibr" rid="CR26">1995</xref>).<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Plasmids used in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Plasmid</th><th align="left">Description</th><th align="left">Reference</th></tr></thead><tbody><tr><td align="left">pDD67</td><td align="left"><italic>Cla</italic>I-<italic>Eco</italic>RI insert of <italic>TAF14</italic> (including 760&#x000a0;bp of 5&#x02032; UTR and 360&#x000a0;bp of 3&#x02032; UTR) in pRS316</td><td align="left">(Welch et al. <xref ref-type="bibr" rid="CR75">1993</xref>)</td></tr><tr><td align="left">pBS1539</td><td align="left">URA3-marked plasmid containing a C-terminal TAP tagging cassette</td><td align="left">(Puig et al. <xref ref-type="bibr" rid="CR57">2001</xref>)</td></tr><tr><td align="left">pCP3</td><td align="left"><italic>Cla</italic>I-<italic>Bam</italic>HI 5&#x02032; and <italic>Eag</italic>I-<italic>Sac</italic>I 3&#x02032; UTR fragment of <italic>TAF</italic>14 from pDD67 inserted into pRS316</td><td align="left">This study</td></tr><tr><td align="left">pCP4</td><td align="left"><italic>Nde</italic>I-<italic>Bgl</italic>II <italic>taf</italic>14[<italic>YEATS</italic>] fragment (aa 6&#x02013;113 of <italic>TAF</italic>14) from pDD69 inserted into pCP3</td><td align="left">This study</td></tr><tr><td align="left">pCP5</td><td align="left"><italic>Nde</italic>I-<italic>Bgl</italic>II <italic>taf</italic>14[<italic>CT</italic>] fragment (aa 113&#x02013;244 of <italic>TAF</italic>14) from pDD69 inserted into pCP3</td><td align="left">This study</td></tr><tr><td align="left">pCP6</td><td align="left"><italic>Nde</italic>I-<italic>Bgl</italic>II <italic>taf</italic>14[-<italic>NT</italic>] fragment (aa 61&#x02013;244 of <italic>TAF</italic>14) from pDD69 inserted into pCP3</td><td align="left">This study</td></tr><tr><td align="left">pDD69</td><td align="left"><italic>Bam</italic>HI-<italic>Eco</italic>RI 760&#x000a0;bp insert of <italic>TAF</italic>14 in pGEX-2T</td><td align="left">(Welch and Drubin <xref ref-type="bibr" rid="CR74">1994</xref>)</td></tr><tr><td align="left">pJS02</td><td align="left"><italic>Nde</italic>I-<italic>Bgl</italic>II <italic>taf</italic>14[<italic>FL</italic>] fragment (aa 1&#x02013;244 of <italic>TAF</italic>14) from pDD69 inserted into pCP3</td><td align="left">This study</td></tr><tr><td align="left">pJS03</td><td align="left">pCP6 with amino acid change R<sub>67</sub>A/D<sub>71</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS04</td><td align="left">pCP6 with amino acid change R<sub>75</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS05</td><td align="left">pCP6 with amino acid change E<sub>77</sub>A/E<sub>78</sub>A/Q<sub>79</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS06</td><td align="left">pCP6 with amino acid change W<sub>81</sub>A/F<sub>84</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS06-A</td><td align="left">pCP4 with amino acid change W<sub>81</sub>A/F<sub>84</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS07</td><td align="left">pCP6 with amino acid change W<sub>81</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS08</td><td align="left">pCP6 with amino acid change F<sub>84</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS09</td><td align="left">pCP6 with amino acid change D<sub>87</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS10</td><td align="left">pCP6 with amino acid change E<sub>94</sub>A/K<sub>95</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS11</td><td align="left">pCP6 with amino acid change E<sub>98</sub>A/R<sub>99</sub>A/K<sub>100</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS12</td><td align="left">pCP6 with amino acid change H<sub>103</sub>A/D<sub>104</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS13</td><td align="left">pCP6 with amino acid change Q<sub>109</sub>A/E<sub>110</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS14</td><td align="left">pCP6 with amino acid change E<sub>113</sub>A/E<sub>115</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS15</td><td align="left">pCP6 with amino acid change K<sub>124</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS16</td><td align="left">pCP6 with amino acid change E<sub>129</sub>A/E<sub>130</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS17</td><td align="left">pCP6 with amino acid change K<sub>133</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS18</td><td align="left">pJS02 with amino acid change R<sub>67</sub>A/D<sub>71</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS19</td><td align="left">pJS02 with amino acid change R<sub>75</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS20</td><td align="left">pJS02 with amino acid change E<sub>77</sub>A/E<sub>78</sub>A/Q<sub>79</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS21</td><td align="left">pJS02 with amino acid change W<sub>81</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS22</td><td align="left">pJS02 with amino acid change F<sub>84</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS23</td><td align="left">pJS02 with amino acid change D<sub>87</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS24</td><td align="left">pJS02 with amino acid change E<sub>94</sub>A/K<sub>95</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS25</td><td align="left">pJS02 with amino acid change E<sub>98</sub>A/R<sub>99</sub>A/K<sub>100</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS26</td><td align="left">pJS02 with amino acid change H<sub>103</sub>A/D<sub>104</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS27</td><td align="left">pJS02 with amino acid change Q<sub>109</sub>A/E<sub>110</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS28</td><td align="left">pJS02 with amino acid change E<sub>113</sub>A/E<sub>115</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS29</td><td align="left">pJS02 with amino acid change K<sub>124</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS30</td><td align="left">pJS02 with amino acid change E<sub>129</sub>A/E<sub>130</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS31</td><td align="left">pJS02 with amino acid change K<sub>133</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS32</td><td align="left">pJS02 with amino acid change R<sub>67</sub>A/D<sub>71</sub>A/E<sub>77</sub>A/E<sub>78</sub>A/Q<sub>79</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS33</td><td align="left">pJS02 with amino acid change K<sub>161</sub>A/K<sub>163</sub>A/K<sub>166</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pJS40</td><td align="left">pVV223 with TAP-<italic>taf</italic>14[<italic>FL</italic>]</td><td align="left">This study</td></tr><tr><td align="left">pJS41</td><td align="left">pVV223 with TAP-<italic>taf</italic>14[<italic>CT</italic>]</td><td align="left">This study</td></tr><tr><td align="left">pJS42</td><td align="left">pVV223 with TAP-<italic>taf</italic>14[<italic>YEATS</italic>]</td><td align="left">This study</td></tr><tr><td align="left">pJS47</td><td align="left">pCP5 with amino acid change K<sub>161</sub>A/K<sub>163</sub>A/K<sub>166</sub>A</td><td align="left">This study</td></tr><tr><td align="left">pRS316</td><td align="left">URA3 f1 ori (<italic>Nae</italic>I) T7 prom. lacZ&#x02032;/MCS T3 promt. pMB1 ori bla CEN6 ARSH4</td><td align="left">(Sikorski and Hieter <xref ref-type="bibr" rid="CR66">1989</xref>)</td></tr><tr><td align="left">pVV223</td><td align="left">Expression vector for N-terminal 4-TAP tagged fusion protein under <italic>PGK</italic> promt.</td><td align="left">(Van Mullem et al. <xref ref-type="bibr" rid="CR71">2003</xref>)</td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Yeast strains used in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Strain</th><th align="left">Genotype</th><th align="left">Reference</th></tr></thead><tbody><tr><td align="left">CH1305</td><td align="left"><italic>MAT</italic>a <italic>ade2 ade3 ura3 leu2 lys2</italic></td><td align="left">C. Holm</td></tr><tr><td align="left">CMKy24</td><td align="left"><italic>MAT</italic>a <italic>ade2 ade3 ura3 leu2 lys2 trp1::hisG dst1&#x00394;::hisG-URA3-hisG</italic></td><td align="left">(Davie and Kane <xref ref-type="bibr" rid="CR13">2000</xref>)</td></tr><tr><td align="left">CMKy70</td><td align="left"><italic>MAT</italic><bold>a</bold><italic>ade2 ade3 ura3 leu2 lys2 taf14&#x00394;::kan</italic></td><td align="left">(Fish et al. <xref ref-type="bibr" rid="CR21">2006</xref>)</td></tr><tr><td align="left">CMKy91</td><td align="left"><italic>MAT</italic>a<italic>/MAT&#x003b1; dst1&#x00394;::hisG/dst1&#x00394;::hisG TAF14/taf14&#x00394;::kan</italic></td><td align="left">(Fish et al. <xref ref-type="bibr" rid="CR21">2006</xref>)</td></tr><tr><td align="left">Ino80-flag &#x02206;anc1</td><td align="left"><italic>S288C MATa his3&#x00394;200 leu2&#x00394; met15&#x00394; trp1&#x00394;63 ura3&#x00394; anc1&#x00394;::HIS3 INO80-FLAG</italic></td><td align="left">X. Shen</td></tr><tr><td align="left">W303-1a</td><td align="left"><italic>MAT</italic>a <italic>ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1</italic></td><td align="left">R. Rothstein</td></tr><tr><td align="left">W303A</td><td align="left"><italic>MAT</italic>a <italic>ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14&#x02206;::ClonNAT</italic></td><td align="left">This study</td></tr><tr><td align="left">W303A-Sas3</td><td align="left"><italic>MAT</italic>a <italic>ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14&#x02206;::ClonNAT FLAG-SAS3</italic></td><td align="left">This study</td></tr><tr><td align="left">W303A-Snf5</td><td align="left"><italic>MAT</italic>a <italic>ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14&#x02206;::ClonNAT HA-SNF5</italic></td><td align="left">This study</td></tr><tr><td align="left">W303A-Sth1</td><td align="left"><italic>MAT</italic>a <italic>ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14&#x02206;::ClonNAT FLAG-STH1</italic></td><td align="left">This study</td></tr><tr><td align="left">W303A-Taf1</td><td align="left"><italic>MAT</italic>a <italic>ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14&#x02206;::ClonNAT FLAG-TAF1</italic></td><td align="left">This study</td></tr><tr><td align="left">W303A-Tfg1</td><td align="left"><italic>MAT</italic>a <italic>ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14&#x02206;::ClonNAT FLAG-TFG1</italic></td><td align="left">This study</td></tr><tr><td align="left">W303A-Taf2</td><td align="left"><italic>MAT</italic>a <italic>ade2-1 ura3-1 leu2-3 112 his3-11 trp1-1 taf14&#x02206;::ClonNAT FLAG-TAF2</italic></td><td align="left">This study</td></tr></tbody></table></table-wrap></p><p>Media such as YPD or synthetic complete (SC) were prepared according to standard procedures (Guthrie et al. <xref ref-type="bibr" rid="CR27">1991</xref>). All chemicals were from Sigma&#x02013;Aldrich unless otherwise noted. SE media was prepared as SC but by substituting the nitrogen source with 1&#x000a0;g/L of glutamic acid (monosodium salt). G418 Sulfate was added to autoclaved YPD or SE media at a concentration of 200&#x000a0;&#x003bc;g/mL. ClonNAT (WERNER BioAgents) was added to autoclaved media at 100&#x000a0;&#x003bc;g/mL. 6-Azauracil (6-AU) was added to autoclaved media at a final concentration of 60&#x000a0;&#x003bc;g/mL; NaCl, KCl, and sorbitol were included at a final concentration of 0.9, 1.2 and 1.8&#x000a0;M, respectively. Benomyl was added immediately after autoclaving media at a concentration of 35&#x000a0;&#x003bc;g/mL, from a stock solution at 10&#x000a0;mg/mL in dimethyl sulfoxide.</p><p>For the growth studies on plates, cells in exponential phase were diluted to an OD<sub>600</sub> of 0.1 and four serial 10&#x000d7; dilutions were made. The same volume of cells was applied onto YPD or SC-URA plates with or without additions as indicated in the text. Cells were grown at 24, 30, or 36&#x000b0;C. For the growth studies in liquid media, cells in early stationary phase were diluted to an OD<sub>600</sub> of 0.05 and grown at 30&#x000b0;C. Samples were taken every 1&#x000a0;h. The mean of the doubling times was calculated with data from exponential phase (OD<sub>600</sub> 0.18&#x02013;2.0). All the <italic>R</italic>P<sup>2P</sup> were larger than 0.9.</p></sec><sec id="Sec4"><title>Strain recovery and tetrad analysis</title><p>The ability of various <italic>TAF14</italic> constructs to complement the synthetic lethality in the <italic>taf14&#x00394;dst1&#x00394;</italic> strain was determined by tetrad analysis of heterozygous diploids. After sporulation of the <italic>TAF14/taf14&#x00394;::kan</italic><sup><italic>r</italic></sup><italic>, dst1&#x00394;::hisG/dst1&#x00394;::hisG</italic> diploid (CMKy91) containing the different <italic>TAF14</italic> constructs on a URA-marked plasmid, the tetrads were dissected onto YPD solid media (plate A) which was then incubated at 26&#x000b0;C for 5&#x02013;7&#x000a0;days. The colony size at every spore position was noted. In the case of extremely small colonies, the cells were transferred to fresh YPD media (plate B) and incubated for 1&#x000a0;week at 26&#x000b0;C. Colonies on YPD were replica plated to SC-URA media with or without G418 to determine genotypes of the colonies.</p></sec><sec id="Sec5"><title>Whole cell extract and protein analysis</title><p>Cell extracts for protein expression analyses were made using the post-alkaline extraction method (Kushnirov <xref ref-type="bibr" rid="CR43">2000</xref>).</p><p>Standard Western blotting conditions with SDS-PAGE gels were used (Sambrook and Russell <xref ref-type="bibr" rid="CR59">2001</xref>). Protein was transferred to nitrocellulose at 100&#x000a0;mV for 1&#x000a0;h and processed for immunoblotting. Primary antibodies were used in the following concentration: polyclonal anti-Taf14, 1:1,000; monoclonal anti-Flag, M2 (Sigma), 1:1,000; monoclonal anti-H+-vacuolar ATPase (Molecular Probes), 1:5,000; anti-PGK (molecular Probes), 1:5,000; and monoclonal anti-HA, clone HA-7 (Sigma), 1:5,000. The secondary ECL<sup>TM</sup> anti-rabbit IgG horseradish peroxidase (HRP) labeled antibody (Amersham) was used at 1:5,000, and the secondary ECL<sup>TM</sup> anti-mouse IgG horseradish peroxidase labeled antibody (Amersham) was used at 1:10,000. The detection of the immobilized proteins conjugated to HRP labeled antibodies was made by using ECL Plus western blotting detection reagents (Amersham-GE Healthcare).</p></sec><sec id="Sec6"><title>Immunofluorescence microscopy</title><p>Asynchronous early log phase yeast cells (5&#x000a0;mL) were fixed with 5% formaldehyde (from a 37% stock solution added directly to the culture) for 1&#x000a0;h at 25&#x000b0;C on a rotator. Formaldehyde was removed by washing twice with 2&#x000a0;mL 0.1&#x000a0;M potassium phosphate buffer (pH 7.5). Cells were resuspended in 1&#x000a0;mL 0.1&#x000a0;M potassium phosphate buffer (pH 7.5) and 500&#x000a0;&#x003bc;L of cell suspension was permeabilized by the addition of 1&#x000a0;&#x003bc;L 14&#x000a0;M &#x003b2;-mercaptoethanol and 5.1&#x000a0;&#x003bc;L 5&#x000a0;mg/mL Zymolyase 20T (USB). After digestion at 37&#x000b0;C for 35&#x000a0;min, the cells were pelleted, and resuspended in 500&#x000a0;&#x003bc;l 0.1&#x000a0;M potassium phosphate buffer (pH 7.5). Ten microliters of cell suspension was then applied to polylysine coated slides (Fisher) and air dried. After rehydrating by immersion in 1&#x000d7; PBS for 5&#x000a0;min, cells were fixed for 6&#x000a0;min in methanol and 30&#x000a0;s in acetone, both at &#x02212;20&#x000b0;C. Cells were blocked with BLOTTO [1&#x000d7; phosphate buffered saline (PBS), 0.05% Tween-20, 5% nonfat dry milk] for 15&#x000a0;min at room temperature. Affinity purified anti-Taf14 antibody (kind gift of David Drubin, UC Berkeley) was added in BLOTTO at a 1:50 dilution. Incubations continued for 12&#x02013;16&#x000a0;h at 4&#x000b0;C in a humidified chamber. After washing twice with BLOTTO, 15&#x000a0;min each, Alexa Fluor 488<sup>&#x000ae;</sup> goat anti-rabbit IgG (H&#x000a0;+&#x000a0;L) (Molecular Probes) was added in BLOTTO at a 1:200 dilution. Incubations continued for 1&#x000a0;h at 25&#x000b0;C in the dark in a humidified chamber. Slides were washed twice for 15&#x000a0;min each in PBS. Slides were mounted in DABCO mounting medium (2.5% w/v DABCO, Sigma #D-2522, 50&#x000a0;mM Tris pH 7.5, 90% glycerol) containing 2&#x000a0;&#x003bc;g/mL DAPI. Coverslips were sealed with nail polish and stored at 4&#x000b0;C in the dark.</p></sec><sec id="Sec7"><title>Inmunoprecipitation</title><p>N-terminal TAP-tagged Taf14 constructs were made with GatewayP<sup>TMP</sup> Cloning technology (Invitrogen) (Van Mullem et al. <xref ref-type="bibr" rid="CR71">2003</xref>). Three entry clones were generated containing the Taf14 constructs: Taf14 (1&#x02013;244), taf14[CT] (113&#x02013;244) and taf14[YEATS] (6&#x02013;113), following the manufacturer&#x02019;s instructions. From each clone, the ORF was subcloned into the high copy plasmid pVV223 creating N-terminal TAP-tagged expression clones under the <italic>PGK</italic> promoter.</p><p>Genomic N-terminal FLAG tagged Taf2, Sth1, Sas3, Ino80, Tfg1, Taf1 and genomic N-terminal HA-tagged Snf5 (strains: W303-A-Snf5, Ino80-FLAG, W303-A-Sth1, W303-A-Sas3, W303-A-Tfg1, W303-A-Taf1 and W303-A-Taf2) were transformed with the three different truncated TAP-<italic>Taf14</italic> mutants. The strains were grown in 150&#x000a0;mL SE-URA/ClonNAT/G418 to log phase. Next, 150 OD<sub>600</sub> units were harvested (~0.4&#x000a0;g pellet). The cell pellet was washed in 10&#x000a0;mL of cold PBS (130&#x000a0;mM NaCl, 7&#x000a0;mM Na<sub>2</sub>HPO<sub>4</sub>-2H<sub>2</sub>O, 3&#x000a0;mM NaH<sub>2</sub>PO<sub>4</sub>-2H<sub>2</sub>O adjusted to pH 7.0), pelleted again, and resuspended in 1&#x000a0;mL PBS. After another centrifugation, the cell pellet was resuspended in 0.6&#x000a0;mL TAP-Ca<sup>2+</sup>-Buffer [50&#x000a0;mM Tris&#x02013;Cl pH 7.5, 200&#x000a0;mM NaCl, 1.5&#x000a0;mM MgAc, 2&#x000a0;mM CaClB<sub>2</sub>, 0.15% NP40, 1&#x000a0;mM DTT and one mini protease inhibitor tablet (Roche) per 5&#x000a0;mL], and the tube was filled with acid-washed glass beads (425&#x02013;600&#x000a0;&#x000b5;m, Sigma). The cells were disrupted mechanically using a bead beater (BioSpec Products, Bartlesville, Oklahoma, USA) 5 times for 20&#x000a0;s with 1-min steps on ice in between. The glass beads were removed by centrifugation at 250&#x000a0;&#x000d7;&#x000a0;<italic>g</italic>. The unbroken cells and the insoluble material were removed by centrifugation at 4&#x000b0;C, 20,000&#x000a0;&#x000d7;&#x000a0;<italic>g</italic> for 20&#x000a0;min. The supernatant of each sample was mixed with 50&#x000a0;&#x003bc;L of TAP-Ca<sup>2+</sup>-Buffer equilibrated Calmodulin Affinity Resin (Stratagene) and incubated with rotating at 4&#x000b0;C for 60&#x000a0;min. The beads were pelleted and washed four times with 0.6&#x000a0;mL TAP-Ca<sup>2+</sup>-Buffer, rotating for 10&#x000a0;min during each wash. They were then resuspended in 100&#x000a0;&#x003bc;L 2&#x000d7; SDS sample buffer (50&#x000a0;mM Tris&#x02013;Cl pH 6.8, 2% SDS, 10% glycerol, 0.025% bromophenol blue) and resolved on a 7.5% SDS-polyacrylamide gel. After transferring to a nitrocellulose membrane, the gel was immunoblotted with monoclonal antibody against FLAG or HA peptides, and a polyclonal antibody against Taf14 as described above under protein analysis.</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>The YEATS domain inhibits growth under different stress conditions</title><p>To dissect the functional regions of Taf14 and decipher the role of its N-terminal YEATS domain, we created several deletion mutants (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b). All the mutants were expressed on a plasmid under <italic>TAF14</italic>&#x02019;s own promoter and regulatory sequences in a <italic>taf14</italic> disruption strain. The expression of all mutant proteins was similar to wild type except for the taf14[YEATS] construct which was expressed or detected poorly (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>c, left panel). Despite this detection problem, there is no doubt of its expression as the phenotypes for this mutant are completely different than the phenotypes for the <italic>taf14</italic> deletion mutant (see below). The cellular localization of all the constructs was also studied and while the taf14[CT] and the taf14[-NT] proteins were located in the nucleus as was the wild-type protein (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>), taf14[YEATS] was practically undetectable with the Taf14 antibody (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). This result is consistent with its low detection by Western blots (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>c, left panel).<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Fluorescence microscopy of <italic>taf14</italic> mutants&#x02019; intracellular localization. <italic>taf14&#x00394;</italic> cells containing different plasmids expressing Taf14 constructs under its natural promoter were fixed and immunostained with a polyclonal Taf14 antibody (<italic>left panels</italic>, <italic>green</italic>). The <italic>center panels</italic> show nuclei in DAPI stained cells (<italic>blue</italic>). The <italic>right panels</italic> show the result of merging the immunostaining and the DAPI staining. Pictures represent a single image plane following deconvolution. Cells contained the wild-type Taf14 (<italic>top panel</italic>); or the taf14[CT] construct (<italic>second panel</italic>); or the taf14[-NT] construct (<italic>third panel</italic>); or the taf14[YEATS] construct (<italic>fourth panel</italic>); or the empty vector pCP3 with the 5&#x02032; and 3&#x02032; UTR of Taf14 as a negative control to determine the background (<italic>bottom panel</italic>)</p></caption><graphic xlink:href="438_2010_523_Fig2_HTML" id="MO2"/></fig></p><p>In synthetic media lacking uracil (SC-URA) at 30&#x000b0;C, cells expressing the Taf14 construct missing the complete YEATS domain (taf14[CT]) had a growth rate comparable to cells expressing wild-type Taf14. In contrast, cells expressing the YEATS domain alone (taf14[YEATS]) or a construct with partial deletion of the YEATS domain (taf14[-NT]) showed a diminished growth rate (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). In the case of cells expressing taf14[YEATS], the doubling time was 1.6 times slower than the <italic>taf14&#x00394;</italic> mutant (CMKy70) and 2.8 times slower than wild-type cells. In addition, the lag phase of cells expressing taf14[YEATS] was more than four times longer than that of the wild-type cells (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Doubling times and lag times prior to entering into exponential phase</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Strain</th><th align="left">Doubling time (h)</th><th align="left">Lag phase (h)</th></tr></thead><tbody><tr><td align="left">CMKy70/pJS02 (<italic>TAF14</italic>)</td><td align="left">2.60&#x000a0;&#x000b1;&#x000a0;0.04</td><td align="left">8.00&#x000a0;&#x000b1;&#x000a0;0.50</td></tr><tr><td align="left">CMKy70/pCP5 (<italic>taf14[CT]</italic>)</td><td align="left">2.97&#x000a0;&#x000b1;&#x000a0;0.18</td><td align="left">7.56&#x000a0;&#x000b1;&#x000a0;0.20</td></tr><tr><td align="left">CMKy70/pCP6 (<italic>taf14[-NT]</italic>)</td><td align="left">3.90&#x000a0;&#x000b1;&#x000a0;0.72</td><td align="left">12.58&#x000a0;&#x000b1;&#x000a0;2.01</td></tr><tr><td align="left">CMKy70/pJS06 (<italic>taf14[-NT</italic><sub><italic>W81A/F84A</italic></sub><italic>]</italic>)</td><td align="left">3.44&#x000a0;&#x000b1;&#x000a0;0.28</td><td align="left">14.15&#x000a0;&#x000b1;&#x000a0;2.23</td></tr><tr><td align="left">CMKy70/pCP4 (<italic>taf14[YEATS]</italic>)</td><td align="left">7.46&#x000a0;&#x000b1;&#x000a0;1.95</td><td align="left">34.60&#x000a0;&#x000b1;&#x000a0;11.13</td></tr><tr><td align="left">CMKy70/pJS06-A (<italic>taf14[YEATS</italic><sub><italic>W81A/F84A</italic></sub><italic>]</italic>)</td><td align="left">9.60&#x000a0;&#x000b1;&#x000a0;2.36</td><td align="left">32.14&#x000a0;&#x000b1;&#x000a0;8.01</td></tr><tr><td align="left">CMKy70</td><td align="left">4.59&#x000a0;&#x000b1;&#x000a0;1.00</td><td align="left">12.54&#x000a0;&#x000b1;&#x000a0;2.45</td></tr></tbody></table><table-wrap-foot><p>All the liquid cultures were started at OD<sub>600</sub> 0.05 from cells in stationary phase and grown at 30&#x000b0;C in SC-URA, except for CMKy70 that was grown in SC media. Values are the average from at least four different cultures</p></table-wrap-foot></table-wrap></p><p>The Taf14 deletion constructs were further tested for their ability to complement the temperature sensitivity of a <italic>taf14</italic> disruption strain CMKy70 (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>, left panel). Taf14[CT] grew as well as wild type at 36&#x000b0;C (and at 24&#x000b0;C). In contrast, taf14[YEATS] could not complement the temperature sensitivity at 36&#x000b0;C. Interestingly, taf14[-NT] could partially complement the growth at 36&#x000b0;C as it did during growth at 30&#x000b0;C cited above. These phenotypes were fully recessive to wild-type Taf14 (Fig.&#x000a0;S1).<table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Relative growth with different chemical compounds of <italic>taf14&#x00394;</italic> strain and strains expressing truncated versions of Taf14</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left" colspan="2">&#x02013;</th><th align="left" colspan="2">NaCl (0.9&#x000a0;M)</th><th align="left" colspan="2">Benomyl (35&#x000a0;&#x003bc;g/mL)</th><th align="left" colspan="2">Caffeine (3&#x000a0;mM)</th><th align="left" colspan="2">6-AU (60&#x000a0;&#x003bc;g/mL)</th><th align="left" colspan="2">Formamide (2%)</th><th align="left" colspan="2">Mycoph. ac (25&#x000a0;&#x003bc;g/mL)</th></tr><tr><th align="left"/><th align="left">24&#x000b0;</th><th align="left">36&#x000b0;</th><th align="left">24&#x000b0;</th><th align="left">36&#x000b0;</th><th align="left">24&#x000b0;</th><th align="left">36&#x000b0;</th><th align="left">24&#x000b0;</th><th align="left">36&#x000b0;</th><th align="left">24&#x000b0;</th><th align="left">36&#x000b0;</th><th align="left">24&#x000b0;</th><th align="left">36&#x000b0;</th><th align="left">24&#x000b0;</th><th align="left">36&#x000b0;</th></tr></thead><tbody><tr><td align="left">CMKy70/pJS02 (TAF14)</td><td align="left">++</td><td align="left">++</td><td align="left">++</td><td align="left">++</td><td align="left">+</td><td align="left">+</td><td align="left">++</td><td align="left">&#x000b1;</td><td align="left">+</td><td align="left">&#x000b1;</td><td align="left">++</td><td align="left">&#x02212;</td><td align="left">++</td><td align="left">&#x000b1;</td></tr><tr><td align="left">CMKy70/pCP5 (taf14[CT])</td><td align="left">++</td><td align="left">++</td><td align="left">++</td><td align="left">++</td><td align="left">++</td><td align="left">++</td><td align="left">++</td><td align="left">+</td><td align="left">++</td><td align="left">&#x000b1;</td><td align="left">++</td><td align="left">+</td><td align="left">++</td><td align="left">&#x000b1;</td></tr><tr><td align="left">CMKy70/pCP6 (taf14[-NT])</td><td align="left">+</td><td align="left">&#x000b1;</td><td align="left">&#x000b1;</td><td align="left">&#x02212;</td><td align="left">&#x000b1;</td><td align="left">&#x000b1;</td><td align="left">+</td><td align="left">&#x000b1;</td><td align="left">+</td><td align="left">&#x02212;</td><td align="left">&#x000b1;</td><td align="left">&#x02212;</td><td align="left">+</td><td align="left">&#x02212;</td></tr><tr><td align="left">CMKy70/pCP4 (taf14[YEATS])</td><td align="left">&#x000b1;</td><td align="left">&#x02212;</td><td align="left">&#x02212;</td><td align="left">&#x02212;</td><td align="left">&#x000b1;</td><td align="left">&#x02212;</td><td align="left">&#x000b1;</td><td align="left">&#x02212;</td><td align="left">&#x000b1;</td><td align="left">&#x02212;</td><td align="left">&#x02212;</td><td align="left">&#x02212;</td><td align="left">&#x02212;&#x02212;</td><td align="left">&#x02212;</td></tr><tr><td align="left">CMKy70</td><td align="left">+</td><td align="left">&#x02212;</td><td align="left">&#x02212;</td><td align="left">&#x02212;</td><td align="left">&#x000b1;</td><td align="left">&#x02212;</td><td align="left">&#x000b1;</td><td align="left">&#x02212;</td><td align="left">&#x000b1;</td><td align="left">&#x02212;</td><td align="left">&#x02212;</td><td align="left">&#x02212;</td><td align="left">&#x02212;</td><td align="left">&#x02212;</td></tr></tbody></table><table-wrap-foot><p>Cells were spotted in 10&#x000d7; serial dilutions onto SC-URA plates containing the indicated concentrations of NaCl, benomyl, caffeine, 6-azauracil (6-AU), formamide, and mycophenolic acid (Mycoph. ac.). Cells were grown at 24 and 36&#x000b0;C for 3&#x000a0;days, except that the benomyl and 6-AU plates were compared after 5 and 6&#x000a0;days, respectively. All the conditions were repeated a minimum of three times</p><p>++, growth the same as CMKy70/pJS02 (<italic>TAF14</italic>) on SC-URA at 24&#x000b0;C; +, slow growth; &#x000b1;, very slow growth; &#x02212;, no growth after 9&#x000a0;days</p></table-wrap-foot></table-wrap></p><p>Since a <italic>taf14</italic> deletion strain is sensitive to different genotoxic stressors, we also tested the effect of the constructs on cell growth under different stress conditions (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) at both permissive (24&#x000b0;C) and non-permissive (36&#x000b0;C) temperatures. As expected from the described results above, taf14[CT] showed no growth disadvantage compared to the wild-type strain. Unexpectedly however, it displayed a growth <italic>advantage</italic> under certain conditions. This advantage was pronounced in the presence of the microtubule destabilizing drug benomyl, as well as on formamide or caffeine at 36C. A less pronounced advantage was seen in the presence of the nucleotide depleting drug 6-azauracil (6-AU). In contrast, under all tested conditions taf14[-NT] allowed very slow or no growth while taf14[YEATS] could not complement the growth defects of the <italic>taf14</italic> disruption mutant (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). We conclude that under a wide range of conditions, the YEATS domain of Taf14 limits cell growth both alone and in the context of the wild-type protein. These results may also indicate that in wild-type cells, a negative function of the YEATS domain is being regulated. This possibility is further explored in the &#x0201c;<xref rid="Sec12" ref-type="sec">Discussion</xref>&#x0201d;.<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Growth rates of the different taf14 truncated mutants. Growth comparison of CMKy70 containing Taf14, taf14[CT] or taf14[-NT] on a plasmid. Tenfold serial dilutions from exponential phase cells were plated onto SC-URA with or without the indicated drugs (concentrations as in Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Cells on SC-URA and SC-URA with formamide were photographed after 3&#x000a0;days growth; SC-URA with benomyl, after 5&#x000a0;days; SC-URA with 6-AU, after 6&#x000a0;days</p></caption><graphic xlink:href="438_2010_523_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec10"><title>Amino acids W81 and W84 form part of a putative regulator interaction site on the YEATS domain surface</title><p>Given the possible regulatory role of the YEATS domain in the cell cycle, we decided to perform a mutagenic scan of the domain to localize sites within the YEATS domain that were important for its function. We used the <italic>taf14[-NT]</italic> construct since its sensitized phenotype allowed for the observation of mutations that resulted in either increased or decreased growth.</p><p>Knowing that charged amino acids are usually necessary for protein&#x02013;protein interactions, ten different single, double, or triple alanine substitutions of charged amino acid residues were made in the <italic>taf14[-NT]</italic> construct (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a; Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). In addition, we created five different alanine substitutions of highly conserved residues hoping to target an essential docking site (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a; Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). We compared the growth of cells transformed with each of the mutants to that of the strain expressing taf14[-NT] on solid media. Fourteen of the mutants grew similarly to cells harbouring taf14[-NT] (data not shown). However, the double mutant W81A/F84A improved growth (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b). In fact, the growth of this mutant became comparable to that of cells expressing the full length protein at 24, 30 and 37&#x000b0;C. W81A/F84A also showed slightly better growth than unmutagenized taf14[-NT] on both sorbitol and benomyl (data not shown). There was no significant difference between the protein levels of any of these taf14[-NT] mutants (Fig.&#x000a0;S2), arguing against the fact that altered expression levels were responsible for the observed phenotypes. Furthermore, the conserved residues W81 and F84 are predicted to lie on the surface of Taf14 (confirmed by the prediction programs: 3D-PSSM and JNet Secondary Structure Prediction, and Wang et al. <xref ref-type="bibr" rid="CR73">2009</xref>) suggesting that they are not serving a structural role, but instead are involved in binding interactions between Taf14 and other protein regulators.<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p><bold>a</bold> Multiple sequence alignment of the carboxy terminal half of the YEATS domain of Taf14 (61&#x02013;113 aa) compared with other YEATS family proteins. Conserved residues in <italic>bold type</italic>. The point mutations used in this study are marked below Taf14; the <italic>grey boxes</italic> correspond to aminoacids 81 and 84. <bold>b</bold> Quantitative growth comparison of cells with Taf14 mutant constructs. CMY70 (<italic>taf14&#x00394;</italic>) strains containing either pJS02 (<italic>TAF14</italic>), pCP5 (<italic>taf14[CT]</italic>), pCP6 (<italic>taf14[-NT]</italic>), pJS06 (<italic>taf14[-NT</italic><sub><italic>W81A-F84A</italic></sub><italic>]</italic>), pCP4 (<italic>taf14[YEATS]</italic>) or pJS06-A (<italic>taf14[YEATS</italic><sub><italic>W81A-F84A</italic></sub><italic>]</italic>) were grown to exponential phase (OD<sub>600</sub> of 0.8&#x02013;2.0) and 10&#x000d7; serial dilution were plated onto SC-URA. Cells were grown at 24&#x000b0;C and after 3&#x000a0;days the plate was photographed</p></caption><graphic xlink:href="438_2010_523_Fig4_HTML" id="MO4"/></fig></p><p>Interestingly, the same double mutant slightly decreased growth when incorporated into the YEATS construct itself (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>) and had no impact on growth in either liquid or on solid media when inserted into the wild-type Taf14 protein. These results suggest that the putative YEATS domain interaction site extends beyond these two residues, perhaps along the fragment of the YEATS domain missing in the taf14[-NT] mutant.</p></sec><sec id="Sec11"><title>Taf14 residues in the C-terminal domain are important for the synthetic lethal phenotype between <italic>taf14&#x00394;</italic> and <italic>dst1&#x00394;</italic></title><p>Although <italic>TAF14</italic> is not essential, its deletion shows a synthetic lethality with deletion of <italic>DST1,</italic> the Taf14 protein is therefore required for the survival of cells lacking the transcript elongation factor TFIIS (encoded by <italic>DST1</italic>) (Fish et al. <xref ref-type="bibr" rid="CR21">2006</xref>). To determine if the YEATS domain of Taf14 is required for this genetic interaction, we analyzed the different mutants of <italic>TAF14</italic> for their ability to complement the synthetic lethality between <italic>taf14&#x00394;</italic> and <italic>dst1&#x00394;</italic>. Plasmids containing the <italic>taf14</italic> deletion mutants (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b) were transformed into the heterozygous <italic>TAF14/taf14&#x00394;::kan</italic><sup><italic>r</italic></sup>, <italic>dst1&#x00394;::hisG/dst1&#x00394;::hisG</italic> diploid strain and transformants were sporulated at 30&#x000b0;C (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). The taf14[YEATS] construct did not complement the synthetic lethality of the double deletion mutant (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>b), and taf14[-NT] grew slowly, taking 5&#x02013;7&#x000a0;days for the germinating spores to make visible colonies (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>c). However, taf14[CT] complemented to equal levels as the wild-type protein (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>d).<fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>Efficiency of different Taf14 constructs in complementing the synthetic lethality between dst1<italic>&#x00394;</italic> and <italic>taf14&#x00394;</italic>. Heterozygous diploids were transformed with plasmids containing the indicated Taf14 constructs. Tetrad analysis was carried out with each strain. <italic>Grey boxes</italic> represent the <italic>taf14&#x00394;/dst1&#x00394;</italic> double mutant. The <italic>taf14&#x02206;::kan</italic><sup><italic>r</italic></sup> spores were identified by their G418<sup>r</sup> phenotype. The presence of the URA3 marked plasmid was determined by testing growth on SC-URA media. <italic>White boxes</italic> represent the <italic>dst1&#x00394;/TAF14</italic> mutant. <italic>Boxes with X</italic> did not have spores. <bold>a</bold> Tetrad analysis following sporulation of CMKy91 containing pJS02 (<italic>TAF14</italic>). The tetrads were dissected onto YPD medium, and the plate was photographed after 2&#x000a0;days at 24&#x000b0;C. <bold>b</bold> Similar to <bold>a</bold> with plasmid pCP4 (<italic>taf14[YEATS]</italic>). Plates were photographed after 3&#x000a0;days at 24&#x000b0;C. <bold>c</bold> Similar to <bold>a</bold> with plasmid pCP6 (<italic>taf14[-NT]</italic>). Plates were photographed after 7&#x000a0;days at 24&#x000b0;C. <bold>d</bold> Similar to <bold>a</bold> with plasmid pCP5 (<italic>taf14[CT]</italic>). Plates were photographed after 3&#x000a0;days at 24&#x000b0;C. Even after 9&#x000a0;days, no growth was detectable in the <italic>blank spots</italic></p></caption><graphic xlink:href="438_2010_523_Fig5_HTML" id="MO5"/></fig></p><p>We also studied the ability of taf14[CT] or taf14[-NT] mutants to complement the temperature sensitivity in the <italic>taf14&#x00394;dst1&#x00394;</italic> background (conferred by the absence of Taf14). As in the <italic>taf14&#x00394;</italic> background (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>, left bottom panel), the <italic>taf14&#x00394;dst1&#x00394;</italic> strain expressing the taf14[CT] construct grew as well as the strain expressing the wild-type construct at 36&#x000b0;C. But the cells containing the <italic>taf14[-NT]</italic> construct grew poorly although this protein was able to complement the temperature sensitivity.</p><p>We next tested the ability of point mutants in <italic>taf14[-NT]</italic> (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>) to complement the synthetic lethality between <italic>taf14&#x00394;</italic> and <italic>dst1&#x00394;</italic> (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). The double mutant W81A/F84A conferred a growth advantage in the <italic>taf14&#x00394;dst1&#x00394;</italic> cells, as it did in the <italic>taf14</italic> null background (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b). Surprisingly, in contrast to our result in the <italic>taf14</italic> null background, three additional mutations outside the YEATS domain conferred a growth advantage in the <italic>taf14&#x00394;dst1&#x00394;</italic> background: K124A, E129A/E130A, and K133A, suggesting that these three C-terminal residues are particularly relevant for the <italic>TAF14</italic> and <italic>DST1</italic> genetic interaction. Thus, we concluded that genetic interaction between <italic>TAF14</italic> and <italic>DST1</italic> is not dependent on the YEATS domain of Taf14 either.<fig id="Fig6"><label>Fig.&#x000a0;6</label><caption><p>Complementation of the <italic>taf14&#x00394; dst1&#x00394;</italic> synthetic lethality by the taf14[-NT*] point mutants. CMKy91 (<italic>taf14&#x00394; dst1&#x00394;</italic>) cells containing either pJS02 (<italic>TAF14</italic>), pCP5 (<italic>taf14[CT]</italic>), pCP6 (<italic>taf14[-NT]</italic>) or one of the plasmids with point mutations in <italic>taf14[-NT*]</italic> were plated in serial dilutions onto SC-URA and YPD plates. Cells were grown at 24&#x000b0;C for 3&#x000a0;days. Mutants that could rescue the taf14[-NT] slow growth phenotype are marked with <italic>arrows</italic>. The slight growth advantage seen for the H<sub>103</sub>A/D<sub>104</sub>A mutant in this figure was not reproducible</p></caption><graphic xlink:href="438_2010_523_Fig6_HTML" id="MO6"/></fig></p></sec><sec id="Sec12"><title>Taf14 interaction with proteins related to transcription and chromatin</title><p>To determine the region of Taf14 protein required for the physical interaction of Taf14 with RSC, Swi/Snf, Ino80, NuA3, TFIIF and TFIID, we performed small-scale interaction assays.</p><p>Proteins from each complex were FLAG- or HA-tagged in their chromosomal loci. Tagged proteins included: (1) Snf5, thought to coordinate the assembly and nucleosome-remodeling activities of Swi/Snf (Geng et al. <xref ref-type="bibr" rid="CR24">2001</xref>); (2) Sth1, the DNA-dependent ATPase of RSC (Du et al. <xref ref-type="bibr" rid="CR15">1998</xref>); (3) Sas3, the histone acetyl transferase catalytic subunit of NuA3 (John et al. <xref ref-type="bibr" rid="CR33">2000</xref>; Howe et al. <xref ref-type="bibr" rid="CR31">2002</xref>); (4) Ino80, the DNA-dependent ATPase of the Ino80 complex (Shen et al. <xref ref-type="bibr" rid="CR63">2003a</xref>, <xref ref-type="bibr" rid="CR64">b</xref>); (5) Tfg1, the largest subunit of TFIIF that functions in transcription initiation and elongation (Fish et al. <xref ref-type="bibr" rid="CR21">2006</xref>; Khaperskyy et al. <xref ref-type="bibr" rid="CR35">2008</xref>); (6) Taf1, the largest subunit of TFIID, with histone acetyltransferase activity (Mizzen et al. <xref ref-type="bibr" rid="CR48">1996</xref>) and involved in promoter binding and G1/S progression (Tansey and Herr <xref ref-type="bibr" rid="CR70">1997</xref>); (7) Taf2, also a TFIID subunit, stabilizes TFIID binding to the core promoter (Walker et al. <xref ref-type="bibr" rid="CR72">1997</xref>; Martinez et al. <xref ref-type="bibr" rid="CR47">1998</xref>). The addition of the tag to these proteins did not affect the growth of these strains, suggesting that the tag did not impair function (data not shown).</p><p>Full length Taf14, taf14[CT] and taf14[YEATS] were TAP-tagged and expressed from plasmids under the <italic>PGK</italic> promoter (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>c, right panel). Each strain carrying one of the seven FLAG- or HA-tagged proteins was transformed with each of the three different Taf14-encoding plasmids. The incorporation of the Taf14 constructs into the different nuclear complexes was tested by immunoprecipitation experiments using the TAP tag on Taf14, followed by Western blotting with FLAG or HA antibodies to detect the protein in the complexes (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>).<fig id="Fig7"><label>Fig.&#x000a0;7</label><caption><p>Interaction assay between Taf14 and different nuclear complexes. The same amount of soluble protein from extracts of <italic>taf14&#x00394;/FLAG-Tfg1, taf14&#x00394;/FLAG-Sas3, taf14&#x00394;/FLAG-Taf1, taf14&#x00394;/FLAG-Taf2, taf14&#x00394;/HA-Snf5, and taf14&#x00394;/FLAG-Sth1</italic> strains containing plasmids expressing either TAP-tagged wild-type Taf14 (pJS40), TAP-taf14[CT] (pJS41), or the TAP tag alone (pVV223) were processed as described in &#x0201c;<xref rid="Sec2" ref-type="sec">Materials and methods</xref>&#x0201d;. The Western-blotted membranes were incubated with anti-FLAG M2 or anti-HA to visualize the protein representing each complex. The protein A present in the TAP tag allowed for the visualization of all versions of Taf14 (<italic>black arrows</italic>). <italic>Red stars</italic> mark the FLAG and HA-tagged proteins. (CT) represents the TAP-taf14[CT]. (FL) represents the TAP-Taf14. + indicates a cell extract of that strain without expression of Taf14 and was used as a positive control. &#x02212; represents the negative control expressing the TAP tag alone</p></caption><graphic xlink:href="438_2010_523_Fig7_HTML" id="MO7"/></fig></p><p>Both full length Taf14 and mutant taf14[CT] were associated with Swi/Snf, RSC, NuA3, TFIIF and TFIID (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). We could draw no conclusions about the association with Ino80 as it could not be clearly detected in any of the five pull down experiments performed. Additionally, in the case of Swi/Snf, the Taf14[CT] was not always well incorporated and sometimes taf14[CT] appeared to immunoprecipitate more Taf2 than the full length protein itself. These results prevented us from making quantitative conclusions about the associations. Taf14[YEATS] was convincingly (three out of three experiments performed, data not shown) associated with Taf1, one of the TFIID components tested. However, in general the TAP-taf14[YEATS] peptide did not immunoprecipitate successfully and was not readily detected in association with the tested proteins even when the polyclonal anti-Taf14 antibody was used to maximize detection of the YEATS domain. Nevertheless, it is clear that the YEATS domain is not essential for Taf14&#x02019;s association with Swi/Snf, RSC, NuA3, TFIIF or TFIID.</p></sec></sec><sec id="Sec13"><title>Discussion</title><p>The work presented here explores the cellular function of Taf14 and studies the role of its conserved YEATS domain by structure&#x02013;function and mutational analysis of various regions of Taf14. This protein is a member of at least six nuclear proteins complexes that are involved in transcription and chromatin modification (RSC, SWI/SNF, Ino80, NuA3, TFIIF, TFIID and possibly Mediator) (Henry et al. <xref ref-type="bibr" rid="CR30">1994</xref>; Poon et al. <xref ref-type="bibr" rid="CR56">1995</xref>; Cairns et al. <xref ref-type="bibr" rid="CR5">1996</xref>; Du et al. <xref ref-type="bibr" rid="CR15">1998</xref>; Shen et al. <xref ref-type="bibr" rid="CR63">2003a</xref>, <xref ref-type="bibr" rid="CR64">b</xref>; Kabani et al. <xref ref-type="bibr" rid="CR34">2005</xref>). Its deletion renders cells sensitive to high temperature and osmolarity, causes deficiency in both constitutive and induced transcription and leads to altered actin cytoskeleton (Welch et al. <xref ref-type="bibr" rid="CR75">1993</xref>; Henry et al. <xref ref-type="bibr" rid="CR30">1994</xref>; Kimura and Ishihama <xref ref-type="bibr" rid="CR37">2004</xref>). The associations of Taf14 with different complexes and the resulting phenotypes of the disruption strain indicate that this protein might facilitate many nuclear processes in the cell, or that it links different processes to a general common mechanism. Exploring the cellular function of Taf14 and determining the role of its conserved YEATS domain was the focus of this work. We show that the YEATS domain has a negative role in cell growth, and it is not needed to bind the nuclear complexes that contain Taf14 nor to complement the Taf14 synthetic lethality with TFIIS when both proteins are absent from the cell.</p><p>In <italic>S. cerevisiae</italic>, there are three proteins that contain the YEATS domain (Taf14, Yaf9, Sas5), and cells require at least one of these proteins to survive (Zhang et al. <xref ref-type="bibr" rid="CR77">2004</xref>). For this reason, when Taf14 deletion mutations in the YEATS domain were constructed, the initial expectation was that the YEATS domain would stimulate cell growth. However, contrary to expectations, we found that in all the cases tested, the C-terminal domain of Taf14 (taf14[CT]) was sufficient to complement all of the phenotypes of a <italic>taf14</italic> deletion strain. Furthermore, the YEATS domain deletion provides a growth <italic>advantage</italic> compared to wild-type cells under a variety of conditions (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). In addition, a deletion of just the first 61 amino acids in the Taf14 YEATS domain (the taf14[-NT] construct) creates a strain with a growth disadvantage compared to a full deletion of the YEATS domain (aa 6&#x02013;113, the taf14[CT] construct). These results, coupled with the extremely slow growth of cells expressing the YEATS domain alone, strongly suggest that the YEATS domain of Taf14 has an important negative regulatory function. We show that the YEATS domain is not needed for the association of Taf14 with any of the tested nuclear complexes (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). This is consistent with the observation that only the coiled-coil C-terminal domain of Yaf9 is required for its interaction with Esa1, the histone acetyltransferase catalytic subunit of, NuA4, and not its YEATS domain (Zhang et al. <xref ref-type="bibr" rid="CR77">2004</xref>). In the same way, the non-YEATS domain (also a coiled-coil region) of GAS41 is required for interaction with the human TIP60 and SRCAP complexes (Park and Roeder <xref ref-type="bibr" rid="CR53">2006</xref>). Together, these observations suggest that the hypothesized negative effect of the YEATS domain would not be transmitted via the complexes themselves. While it is still formally possible that there may be interactions between Taf14 and other subunits of these complexes that are affected by deletion of the YEATS domain, we prefer a model where the YEATS domain functions outside of the complexes themselves, possibly by binding and modifying growth regulators through a specific binding site on its surface.</p><p>Compatible with the possibility that the YEATS domain contains such a regulatory motif, site-specific mutations (W81A, F84A) in the remaining YEATS residues of taf14[-NT] conferred a growth advantage to cells (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b). These residues are predicted to reside in one of the loops of a &#x003b2;-sandwich, likely on the protein surface. Thus, this region might be critical for interaction with a protein or proteins in the cellular pathway in which the YEATS domain of Taf14 plays a role. The growth rescue of this sensitized mutant via these point mutations argues against the possible misfolding of the construct. This increased growth is not observed when the mutations are incorporated into the full length <italic>TAF14,</italic> but the reason for this result could be that we cannot detect increased growth over that of an already healthy strain. Since the YEATS domain is not required for interaction with at least five of the six complexes in which Taf14 is a subunit, these residues (W81 and F84) are unlikely to be necessary for interaction with the complexes themselves. It seems more likely that these residues are highlighting a regulatory region interacting with other proteins important for Taf14 function. Further, it seems plausible that the YEATS domain is carrying out a function separate from that of the C-terminal domain of Taf14.</p><p>Another feature of <italic>TAF14</italic> is that its disruption makes the gene encoding TFIIS (<italic>DST1</italic>) essential (Fish and Kane <xref ref-type="bibr" rid="CR20">2002</xref>). TFIIS is a transcript elongation factor that allows RNA polymerase II to recover from the backtracked state and read through blocks to elongation such as the nucleosome (Kireeva et al. <xref ref-type="bibr" rid="CR39">2005</xref>). The synthetic lethality between <italic>TAF14</italic> and <italic>DST1</italic> appears to be mediated through TFIIF, both an initiation and an elongation factor in transcription (Fish et al. <xref ref-type="bibr" rid="CR21">2006</xref>). Both taf14[CT] and taf14[-NT<sub>W81A-F84A</sub>] complement the synthetic lethality in a <italic>taf14&#x00394;dst1&#x00394;</italic> strain as effectively as wild-type Taf14 (Figs.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>, <xref rid="Fig6" ref-type="fig">6</xref>). In addition, three other mutants (K124A, E129A/E130A, or K133A) in the taf14[-NT] construct complement as well as wild-type Taf14 (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). Interestingly, none of these residues are located in the YEATS domain, and these mutants do not rescue the slow growth phenotype of the taf14[-NT] mutant in the haploid <italic>taf14&#x00394;</italic> strain. Thus, since these mutant residues do rescue the <italic>taf14&#x00394;dst1&#x00394;</italic> synthetic lethality, they are residues that are needed specifically for the TFIIS function. This result reinforces the likelihood that the YEATS domain and the C-terminal domain are involved in distinct functions.</p><p>Disruption of <italic>TAF14</italic> also renders genes encoding subunits of SWI/SNF essential (Davie and Kane <xref ref-type="bibr" rid="CR13">2000</xref>), and mutant alleles in the two larger subunits of TFIIF are also synthetically lethal with <italic>taf14&#x00394;</italic> (unpublished results). It is possible that more of this type of genetic interaction might be found if direct experiments were done with genes in the other Taf14 bearing-complexes as well. Alternatively, the defects seen in <italic>taf14</italic> null mutants might be explained by disassembled complexes (one or more) or by assembled but functionally inactive complexes. For example, in a <italic>snf5&#x00394;</italic> mutant, Swi/Snf is not well assembled leading to an inactive complex (Geng et al. <xref ref-type="bibr" rid="CR24">2001</xref>). In contrast, <italic>taf14&#x00394;</italic> mutants still contain a stable Swi/Snf complex with ATPase activity (Cairns et al. <xref ref-type="bibr" rid="CR5">1996</xref>) and yeast TFIIF without Taf14 is still active in vitro (Ziegler et al. <xref ref-type="bibr" rid="CR79">2003</xref>). In any case, Taf14&#x02019;s presence in the six nuclear complexes suggests that it might perform a broad function designed to enlist these complexes in particular processes or locations, perhaps at particular times. Clearly Taf14 is not needed in all circumstances as the complexes can function in its absence at the permissive temperature.</p><p>All these observations, together with several others found in the literature (see below), lead to plausible and testable hypotheses. First, it has been reported that the <italic>taf14&#x00394;</italic> cells have elongated buds and actin hyperpolarization (Henry et al. <xref ref-type="bibr" rid="CR30">1994</xref>), phenotypes often associated with cell cycle regulating proteins (Welch and Drubin <xref ref-type="bibr" rid="CR74">1994</xref>). Second, cells lacking Taf14 spend much longer in G1 than do wild-type cells (Erlich et al. <xref ref-type="bibr" rid="CR17">2008</xref>). Third, Taf14 is essential for the G2/M transition in <italic>cdc40&#x00394;</italic> cells (Dahan and Kupiec <xref ref-type="bibr" rid="CR12">2004</xref>), important for cell cycle progression. Fourth, Taf14 is related to two YEATS domain containing mammalian proteins Gas41 and AF-9, both implicated in spindle function. Fifth, Taf14 is a subunit of RSC, a chromatin remodeling complex also essential for cell cycle progression (Du et al. <xref ref-type="bibr" rid="CR15">1998</xref>; Yamada et al. <xref ref-type="bibr" rid="CR76">2008</xref>). Sixth, the YEATS domain containing protein Yaf9 is important for the deposition of H2A.Z (Le Masson et al. <xref ref-type="bibr" rid="CR44">2003</xref>), a histone variant required for proper timing of transcription of cell cycle regulatory proteins. Along this line of thought, the results reported here also suggest a role for Taf14 and its YEATS domain during the cell cycle. While the doubling times of cells containing taf14[-NT] and YEATS constructs are longer than for cells containing the normal Taf14 or the taf14[CT] constructs, the lag time prior to starting cell division is profoundly increased, especially for cells containing the YEATS construct (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). This observation suggests a problem in reentering the cell cycle after stationary phase, perhaps from G<sub>0</sub> to late G<sub>1</sub> where cells commit to DNA replication. Additionally, the taf14[CT] mutant grows better than wild type in the presence of benomyl, a microtubule destabilizing drug (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>), as if the absence of the YEATS domain actually stabilized nuclear microtubules.</p><p>In summary, expression of only the YEATS domain makes the cells sick: a partial YEATS domain in Taf14 imparts slowed growth; a full deletion of the YEATS domain of Taf14 generates healthy cells. Additional experiments will be necessary to find the YEATS-binding regulator, to test, in a quantitative way, what fraction of each nuclear complex has Taf14 and the mutant versions bound, and to determine the importance of the YEATS domain for Taf14&#x02019;s function in the nucleus.</p></sec><sec sec-type="supplementary-material"><sec id="AppESM1"><title>Electronic supplementary material</title><supplementary-material id="d28e2978" content-type="local-data"><p>Below is the link to the electronic supplementary material. </p><media xlink:href="438_2010_523_MOESM1_ESM.tif" id="MOESM1" mimetype="image" mime-subtype="tiff"><caption><p>Supplementary Fig. S1 Effect of taf14 mutants on a wild type strain. Same amounts of CH1305 containing TAP-TAF14 (pJS40), TAP-taf14[CT] (pJS41) and TAP-taf14[YEATS] (pJS42) on plasmids were grown onto SC-URA plates. The empty vector (pVV223) was used as a negative control (TIFF 1022&#x000a0;kb)</p></caption></media><media xlink:href="438_2010_523_MOESM2_ESM.tif" id="MOESM2" mimetype="image" mime-subtype="tiff"><caption><p>Supplementary 2 Fig. S2 Expression level of the different Taf14 mutant constructs in taf14&#x00394; cells. Expression of different Taf14[-NT] mutants. Equal amounts of cell extract were resolved on a 10% SDS-Laemmli protein gel and transferred to a nitrocellulose membrane for western blotting. Proteins were detected with Polyclonal Taf14 antibody. W81A/F84A mutant, in red, is the only one showing an improved growth (Fig. 4) (TIFF 1796&#x000a0;kb)</p></caption></media></supplementary-material></sec></sec></body><back><ack><p>This work was supported by NSF Grant MCB:0316224 grant to C.M.K., Studienstiftung des deutschen Volkes (German National Academic Foundation) to J.M.S., and a Postdoctoral fellowship from the Basque Government to A.R.M.</p><p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adler</surname><given-names>HT</given-names></name><name><surname>Chinery</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>DY</given-names></name><name><surname>Kussick</surname><given-names>SJ</given-names></name><name><surname>Payne</surname><given-names>JM</given-names></name><name><surname>Fornace</surname><given-names>AJ</given-names></name><name><surname>Tkachuk</surname><given-names>DC</given-names></name></person-group><article-title>Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins</article-title><source>Mol Cell Biol</source><year>1999</year><volume>19</volume><fpage>7050</fpage><lpage>7060</lpage><pub-id pub-id-type="pmid">10490642</pub-id></mixed-citation></ref><ref id="CR2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>HJ</given-names></name><name><surname>Kang</surname><given-names>YK</given-names></name><name><surname>Roeder</surname><given-names>RG</given-names></name></person-group><article-title>Human mediator enhances basal transcription by facilitating recruitment of transcription factor IIB during preinitiation complex assembly</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>15172</fpage><lpage>15181</lpage><pub-id pub-id-type="doi">10.1074/jbc.M601983200</pub-id><pub-id pub-id-type="pmid">16595664</pub-id></mixed-citation></ref><ref id="CR3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buratowski</surname><given-names>S</given-names></name><name><surname>Hahn</surname><given-names>S</given-names></name><name><surname>Guarente</surname><given-names>L</given-names></name><name><surname>Sharp</surname><given-names>PA</given-names></name></person-group><article-title>Five intermediate complexes in transcription initiation by RNA polymerase II</article-title><source>Cell</source><year>1989</year><volume>56</volume><fpage>549</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(89)90578-3</pub-id><pub-id pub-id-type="pmid">2917366</pub-id></mixed-citation></ref><ref id="CR4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cairns</surname><given-names>BR</given-names></name></person-group><article-title>Chromatin remodeling complexes: strength in diversity, precision through specialization</article-title><source>Curr Opin Genet Dev</source><year>2005</year><volume>15</volume><fpage>185</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2005.01.003</pub-id><pub-id pub-id-type="pmid">15797201</pub-id></mixed-citation></ref><ref id="CR5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cairns</surname><given-names>BR</given-names></name><name><surname>Henry</surname><given-names>NL</given-names></name><name><surname>Kornberg</surname><given-names>RD</given-names></name></person-group><article-title>TFG/TAF30/ANC1, a component of the yeast SWI/SNF complex that is similar to the leukemogenic proteins ENL and AF-9</article-title><source>Mol Cell Biol</source><year>1996</year><volume>16</volume><fpage>3308</fpage><lpage>3316</lpage><pub-id pub-id-type="pmid">8668146</pub-id></mixed-citation></ref><ref id="CR6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark-Adams</surname><given-names>CD</given-names></name><name><surname>Norris</surname><given-names>D</given-names></name><name><surname>Osley</surname><given-names>MA</given-names></name><name><surname>Fassler</surname><given-names>JS</given-names></name><name><surname>Winston</surname><given-names>F</given-names></name></person-group><article-title>Changes in histone gene dosage alter transcription in yeast</article-title><source>Genes Dev</source><year>1988</year><volume>2</volume><fpage>150</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1101/gad.2.2.150</pub-id><pub-id pub-id-type="pmid">2834270</pub-id></mixed-citation></ref><ref id="CR7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cler</surname><given-names>E</given-names></name><name><surname>Papai</surname><given-names>G</given-names></name><name><surname>Schultz</surname><given-names>P</given-names></name><name><surname>Davidson</surname><given-names>I</given-names></name></person-group><article-title>Recent advances in understanding the structure and function of general transcription factor TFIID</article-title><source>Cell Mol Life Sci</source><year>2009</year><volume>66</volume><fpage>2123</fpage><lpage>2134</lpage><pub-id pub-id-type="doi">10.1007/s00018-009-0009-3</pub-id><pub-id pub-id-type="pmid">19308322</pub-id></mixed-citation></ref><ref id="CR8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conaway</surname><given-names>R</given-names></name><name><surname>Conaway</surname><given-names>J</given-names></name></person-group><article-title>The INO80 chromatin remodeling complex in transcription, replication and repair</article-title><source>Trends Biochem Sci</source><year>2009</year><volume>34</volume><fpage>71</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2008.10.010</pub-id><pub-id pub-id-type="pmid">19062292</pub-id></mixed-citation></ref><ref id="CR9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conaway</surname><given-names>JW</given-names></name><name><surname>Shilatifard</surname><given-names>A</given-names></name><name><surname>Dvir</surname><given-names>A</given-names></name><name><surname>Conaway</surname><given-names>RC</given-names></name></person-group><article-title>Control of elongation by RNA polymerase II</article-title><source>Trends Biochem Sci</source><year>2000</year><volume>25</volume><fpage>375</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1016/S0968-0004(00)01615-7</pub-id><pub-id pub-id-type="pmid">10916156</pub-id></mixed-citation></ref><ref id="CR10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corral</surname><given-names>J</given-names></name><name><surname>Lavenir</surname><given-names>I</given-names></name><name><surname>Impey</surname><given-names>H</given-names></name><name><surname>Warren</surname><given-names>AJ</given-names></name><name><surname>Forster</surname><given-names>A</given-names></name><name><surname>Larson</surname><given-names>TA</given-names></name><name><surname>Bell</surname><given-names>S</given-names></name><name><surname>McKenzie</surname><given-names>AN</given-names></name><name><surname>King</surname><given-names>G</given-names></name><name><surname>Rabbitts</surname><given-names>TH</given-names></name></person-group><article-title>An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes</article-title><source>Cell</source><year>1996</year><volume>85</volume><fpage>853</fpage><lpage>861</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81269-6</pub-id><pub-id pub-id-type="pmid">8681380</pub-id></mixed-citation></ref><ref id="CR11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costelloe</surname><given-names>T</given-names></name><name><surname>Fitzgerald</surname><given-names>J</given-names></name><name><surname>Murphy</surname><given-names>NJ</given-names></name><name><surname>Flaus</surname><given-names>A</given-names></name><name><surname>Lowndes</surname><given-names>NF</given-names></name></person-group><article-title>Chromatin modulation and the DNA damage response</article-title><source>Exp Cell Res</source><year>2006</year><volume>312</volume><fpage>2677</fpage><lpage>2686</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2006.06.031</pub-id><pub-id pub-id-type="pmid">16893724</pub-id></mixed-citation></ref><ref id="CR12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahan</surname><given-names>O</given-names></name><name><surname>Kupiec</surname><given-names>M</given-names></name></person-group><article-title>The <italic>Saccharomyces cerevisiae</italic> gene CDC40/PRP17 controls cell cycle progression through splicing of the ANC1 gene</article-title><source>Nucleic Acids Res</source><year>2004</year><volume>32</volume><fpage>2529</fpage><lpage>2540</lpage><pub-id pub-id-type="doi">10.1093/nar/gkh574</pub-id><pub-id pub-id-type="pmid">15133121</pub-id></mixed-citation></ref><ref id="CR13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davie</surname><given-names>JK</given-names></name><name><surname>Kane</surname><given-names>CM</given-names></name></person-group><article-title>Genetic interactions between TFIIS and the Swi-Snf chromatin-remodeling complex</article-title><source>Mol Cell Biol</source><year>2000</year><volume>20</volume><fpage>5960</fpage><lpage>5973</lpage><pub-id pub-id-type="doi">10.1128/MCB.20.16.5960-5973.2000</pub-id><pub-id pub-id-type="pmid">10913179</pub-id></mixed-citation></ref><ref id="CR14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dechassa</surname><given-names>ML</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Horowitz-Scherer</surname><given-names>R</given-names></name><name><surname>Persinger</surname><given-names>J</given-names></name><name><surname>Woodcock</surname><given-names>CL</given-names></name><name><surname>Peterson</surname><given-names>CL</given-names></name><name><surname>Bartholomew</surname><given-names>B</given-names></name></person-group><article-title>Architecture of the SWI/SNF-nucleosome complex</article-title><source>Mol Cell Biol</source><year>2008</year><volume>28</volume><fpage>6010</fpage><lpage>6021</lpage><pub-id pub-id-type="doi">10.1128/MCB.00693-08</pub-id><pub-id pub-id-type="pmid">18644858</pub-id></mixed-citation></ref><ref id="CR15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Nasir</surname><given-names>I</given-names></name><name><surname>Benton</surname><given-names>BK</given-names></name><name><surname>Kladde</surname><given-names>MP</given-names></name><name><surname>Laurent</surname><given-names>BC</given-names></name></person-group><article-title>Sth1p, a <italic>Saccharomyces cerevisiae</italic> Snf2p/Swi2p homolog, is an essential ATPase in RSC and differs from Snf/Swi in its interactions with histones and chromatin-associated proteins</article-title><source>Genetics</source><year>1998</year><volume>150</volume><fpage>987</fpage><lpage>981005</lpage><pub-id pub-id-type="pmid">9799253</pub-id></mixed-citation></ref><ref id="CR16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberharter</surname><given-names>A</given-names></name><name><surname>John</surname><given-names>S</given-names></name><name><surname>Grant</surname><given-names>PA</given-names></name><name><surname>Utley</surname><given-names>RT</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name></person-group><article-title>Identification and analysis of yeast nucleosomal histone acetyltransferase complexes</article-title><source>Methods</source><year>1998</year><volume>15</volume><fpage>315</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1006/meth.1998.0635</pub-id><pub-id pub-id-type="pmid">9740719</pub-id></mixed-citation></ref><ref id="CR17"><mixed-citation publication-type="other">Erlich R, Fry R, Begley T, Daee D, Lahue R, Samson L (2008) Anc1, a protein associated with multiple transcription complexes, is involved in postreplication repair pathway in <italic>S. cerevisiae</italic>. PLoS ONE 3:e3717</mixed-citation></ref><ref id="CR18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>HY</given-names></name><name><surname>Cheng</surname><given-names>KK</given-names></name><name><surname>Klein</surname><given-names>HL</given-names></name></person-group><article-title>Mutations in the RNA polymerase II transcription machinery suppress the hyperrecombination mutant hpr1 delta of <italic>Saccharomyces cerevisiae</italic></article-title><source>Genetics</source><year>1996</year><volume>142</volume><fpage>749</fpage><lpage>759</lpage><pub-id pub-id-type="pmid">8849885</pub-id></mixed-citation></ref><ref id="CR19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>U</given-names></name><name><surname>Heckel</surname><given-names>D</given-names></name><name><surname>Michel</surname><given-names>A</given-names></name><name><surname>Janka</surname><given-names>M</given-names></name><name><surname>Hulsebos</surname><given-names>T</given-names></name><name><surname>Meese</surname><given-names>E</given-names></name></person-group><article-title>Cloning of a novel transcription factor-like gene amplified in human glioma including astrocytoma grade I</article-title><source>Hum Mol Genet</source><year>1997</year><volume>6</volume><fpage>1817</fpage><lpage>1822</lpage><pub-id pub-id-type="doi">10.1093/hmg/6.11.1817</pub-id><pub-id pub-id-type="pmid">9302258</pub-id></mixed-citation></ref><ref id="CR20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fish</surname><given-names>R</given-names></name><name><surname>Kane</surname><given-names>C</given-names></name></person-group><article-title>Promoting elongation with transcript cleavage stimulatory factors</article-title><source>Biochim Biophys Acta</source><year>2002</year><volume>1577</volume><fpage>287</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">12213659</pub-id></mixed-citation></ref><ref id="CR21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fish</surname><given-names>RN</given-names></name><name><surname>Ammerman</surname><given-names>ML</given-names></name><name><surname>Davie</surname><given-names>JK</given-names></name><name><surname>Lu</surname><given-names>BF</given-names></name><name><surname>Pham</surname><given-names>C</given-names></name><name><surname>Howe</surname><given-names>L</given-names></name><name><surname>Ponticelli</surname><given-names>AS</given-names></name><name><surname>Kane</surname><given-names>CM</given-names></name></person-group><article-title>Genetic interactions between TFIIF and TFIIS</article-title><source>Genetics</source><year>2006</year><volume>173</volume><fpage>1871</fpage><lpage>1884</lpage><pub-id pub-id-type="doi">10.1534/genetics.106.058834</pub-id><pub-id pub-id-type="pmid">16648643</pub-id></mixed-citation></ref><ref id="CR22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores</surname><given-names>O</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Killeen</surname><given-names>M</given-names></name><name><surname>Greenblatt</surname><given-names>J</given-names></name><name><surname>Burton</surname><given-names>ZF</given-names></name><name><surname>Reinberg</surname><given-names>D</given-names></name></person-group><article-title>The small subunit of transcription factor IIF recruits RNA polymerase II into the preinitiation complex</article-title><source>Proc Natl Acad Sci USA</source><year>1991</year><volume>88</volume><fpage>9999</fpage><lpage>10003</lpage><pub-id pub-id-type="doi">10.1073/pnas.88.22.9999</pub-id><pub-id pub-id-type="pmid">1946469</pub-id></mixed-citation></ref><ref id="CR23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores</surname><given-names>O</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Reinberg</surname><given-names>D</given-names></name></person-group><article-title>Factors involved in specific transcription by mammalian RNA polymerase II. Identification and characterization of factor IIH</article-title><source>J Biol Chem</source><year>1992</year><volume>267</volume><fpage>2786</fpage><lpage>2793</lpage><pub-id pub-id-type="pmid">1733973</pub-id></mixed-citation></ref><ref id="CR24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>F</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Laurent</surname><given-names>BC</given-names></name></person-group><article-title>Essential roles of Snf5p in Snf-Swi chromatin remodeling in vivo</article-title><source>Mol Cell Biol</source><year>2001</year><volume>21</volume><fpage>4311</fpage><lpage>4320</lpage><pub-id pub-id-type="doi">10.1128/MCB.21.13.4311-4320.2001</pub-id><pub-id pub-id-type="pmid">11390659</pub-id></mixed-citation></ref><ref id="CR25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghavi-Helm</surname><given-names>Y</given-names></name><name><surname>Michaut</surname><given-names>M</given-names></name><name><surname>Acker</surname><given-names>J</given-names></name><name><surname>Aude</surname><given-names>JC</given-names></name><name><surname>Thuriaux</surname><given-names>P</given-names></name><name><surname>Werner</surname><given-names>M</given-names></name><name><surname>Soutourina</surname><given-names>J</given-names></name></person-group><article-title>Genome-wide location analysis reveals a role of TFIIS in RNA polymerase III transcription</article-title><source>Genes Dev</source><year>2008</year><volume>22</volume><fpage>1934</fpage><lpage>1947</lpage><pub-id pub-id-type="doi">10.1101/gad.471908</pub-id><pub-id pub-id-type="pmid">18628399</pub-id></mixed-citation></ref><ref id="CR26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gietz</surname><given-names>RD</given-names></name><name><surname>Schiestl</surname><given-names>RH</given-names></name><name><surname>Willems</surname><given-names>AR</given-names></name><name><surname>Woods</surname><given-names>RA</given-names></name></person-group><article-title>Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure</article-title><source>Yeast</source><year>1995</year><volume>11</volume><fpage>355</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1002/yea.320110408</pub-id><pub-id pub-id-type="pmid">7785336</pub-id></mixed-citation></ref><ref id="CR27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guthrie</surname><given-names>T</given-names></name><name><surname>Tsuji</surname><given-names>J</given-names></name><name><surname>Wells</surname><given-names>J</given-names></name></person-group><article-title>A synthetic pseudosubstrate peptide of protein kinase C inhibits the phorbol-12, 13-dibutyrate effect on permeabilized coronary artery smooth muscle</article-title><source>Mol Pharmacol</source><year>1991</year><volume>39</volume><fpage>621</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">2034234</pub-id></mixed-citation></ref><ref id="CR28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harborth</surname><given-names>J</given-names></name><name><surname>Weber</surname><given-names>K</given-names></name><name><surname>Osborn</surname><given-names>M</given-names></name></person-group><article-title>GAS41, a highly conserved protein in eukaryotic nuclei, binds to NuMA</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>31979</fpage><lpage>31985</lpage><pub-id pub-id-type="doi">10.1074/jbc.M000994200</pub-id><pub-id pub-id-type="pmid">10913114</pub-id></mixed-citation></ref><ref id="CR29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Battistella</surname><given-names>L</given-names></name><name><surname>Morse</surname><given-names>R</given-names></name></person-group><article-title>Mediator requirement downstream of chromatin remodeling during transcriptional activation of CHA1 in yeast</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>5276</fpage><lpage>5286</lpage><pub-id pub-id-type="doi">10.1074/jbc.M708266200</pub-id><pub-id pub-id-type="pmid">18093974</pub-id></mixed-citation></ref><ref id="CR30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>NL</given-names></name><name><surname>Campbell</surname><given-names>AM</given-names></name><name><surname>Feaver</surname><given-names>WJ</given-names></name><name><surname>Poon</surname><given-names>D</given-names></name><name><surname>Weil</surname><given-names>PA</given-names></name><name><surname>Kornberg</surname><given-names>RD</given-names></name></person-group><article-title>TFIIF-TAF-RNA polymerase II connection</article-title><source>Genes Dev</source><year>1994</year><volume>8</volume><fpage>2868</fpage><lpage>2878</lpage><pub-id pub-id-type="doi">10.1101/gad.8.23.2868</pub-id><pub-id pub-id-type="pmid">7995524</pub-id></mixed-citation></ref><ref id="CR31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howe</surname><given-names>L</given-names></name><name><surname>Kusch</surname><given-names>T</given-names></name><name><surname>Muster</surname><given-names>N</given-names></name><name><surname>Chaterji</surname><given-names>R</given-names></name><name><surname>Yates</surname><given-names>JR</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name></person-group><article-title>Yng1p modulates the activity of Sas3p as a component of the yeast NuA3 histone acetyltransferase complex</article-title><source>Mol Cell Biol</source><year>2002</year><volume>22</volume><fpage>5047</fpage><lpage>5053</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.14.5047-5053.2002</pub-id><pub-id pub-id-type="pmid">12077334</pub-id></mixed-citation></ref><ref id="CR32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imbalzano</surname><given-names>AN</given-names></name><name><surname>Kwon</surname><given-names>H</given-names></name><name><surname>Green</surname><given-names>MR</given-names></name><name><surname>Kingston</surname><given-names>RE</given-names></name></person-group><article-title>Facilitated binding of TATA-binding protein to nucleosomal DNA</article-title><source>Nature</source><year>1994</year><volume>370</volume><fpage>481</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1038/370481a0</pub-id><pub-id pub-id-type="pmid">8047170</pub-id></mixed-citation></ref><ref id="CR33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname><given-names>S</given-names></name><name><surname>Howe</surname><given-names>L</given-names></name><name><surname>Tafrov</surname><given-names>ST</given-names></name><name><surname>Grant</surname><given-names>PA</given-names></name><name><surname>Sternglanz</surname><given-names>R</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name></person-group><article-title>The something about silencing protein, Sas3, is the catalytic subunit of NuA3, a yTAF(II)30-containing HAT complex that interacts with the Spt16 subunit of the yeast CP (Cdc68/Pob3)-FACT complex</article-title><source>Genes Dev</source><year>2000</year><volume>14</volume><fpage>1196</fpage><lpage>1208</lpage><pub-id pub-id-type="pmid">10817755</pub-id></mixed-citation></ref><ref id="CR34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabani</surname><given-names>M</given-names></name><name><surname>Michot</surname><given-names>K</given-names></name><name><surname>Boschiero</surname><given-names>C</given-names></name><name><surname>Werner</surname><given-names>M</given-names></name></person-group><article-title>Anc1 interacts with the catalytic subunits of the general transcription factors TFIID and TFIIF, the chromatin remodeling complexes RSC and INO80, and the histone acetyltransferase complex NuA3</article-title><source>Biochem Biophys Res Commun</source><year>2005</year><volume>332</volume><fpage>398</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2005.04.158</pub-id><pub-id pub-id-type="pmid">15896708</pub-id></mixed-citation></ref><ref id="CR35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khaperskyy</surname><given-names>D</given-names></name><name><surname>Ammerman</surname><given-names>M</given-names></name><name><surname>Majovski</surname><given-names>R</given-names></name><name><surname>Ponticelli</surname><given-names>A</given-names></name></person-group><article-title>Functions of <italic>Saccharomyces cerevisiae</italic> TFIIF during transcription start site utilization</article-title><source>Mol Cell Biol</source><year>2008</year><volume>28</volume><fpage>3757</fpage><lpage>3766</lpage><pub-id pub-id-type="doi">10.1128/MCB.02272-07</pub-id><pub-id pub-id-type="pmid">18362165</pub-id></mixed-citation></ref><ref id="CR36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Bjorklund</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Sayre</surname><given-names>MH</given-names></name><name><surname>Kornberg</surname><given-names>RD</given-names></name></person-group><article-title>A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II</article-title><source>Cell</source><year>1994</year><volume>77</volume><fpage>599</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(94)90221-6</pub-id><pub-id pub-id-type="pmid">8187178</pub-id></mixed-citation></ref><ref id="CR37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Ishihama</surname><given-names>A</given-names></name></person-group><article-title>Tfg3, a subunit of the general transcription factor TFIIF in <italic>Schizosaccharomyces pombe</italic>, functions under stress conditions</article-title><source>Nucleic Acids Res</source><year>2004</year><volume>32</volume><fpage>6706</fpage><lpage>6715</lpage><pub-id pub-id-type="doi">10.1093/nar/gkh1000</pub-id><pub-id pub-id-type="pmid">15616156</pub-id></mixed-citation></ref><ref id="CR38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingston</surname><given-names>RE</given-names></name><name><surname>Narlikar</surname><given-names>GJ</given-names></name></person-group><article-title>ATP-dependent remodeling and acetylation as regulators of chromatin fluidity</article-title><source>Genes Dev</source><year>1999</year><volume>13</volume><fpage>2339</fpage><lpage>2352</lpage><pub-id pub-id-type="doi">10.1101/gad.13.18.2339</pub-id><pub-id pub-id-type="pmid">10500090</pub-id></mixed-citation></ref><ref id="CR39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kireeva</surname><given-names>M</given-names></name><name><surname>Hancock</surname><given-names>B</given-names></name><name><surname>Cremona</surname><given-names>G</given-names></name><name><surname>Walter</surname><given-names>W</given-names></name><name><surname>Studitsky</surname><given-names>V</given-names></name><name><surname>Kashlev</surname><given-names>M</given-names></name></person-group><article-title>Nature of the nucleosomal barrier to RNA polymerase II</article-title><source>Mol Cell</source><year>2005</year><volume>18</volume><fpage>97</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.02.027</pub-id><pub-id pub-id-type="pmid">15808512</pub-id></mixed-citation></ref><ref id="CR40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krogan</surname><given-names>NJ</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Tong</surname><given-names>A</given-names></name><name><surname>Golshani</surname><given-names>A</given-names></name><name><surname>Cagney</surname><given-names>G</given-names></name><name><surname>Canadien</surname><given-names>V</given-names></name><name><surname>Richards</surname><given-names>DP</given-names></name><name><surname>Beattie</surname><given-names>BK</given-names></name><name><surname>Emili</surname><given-names>A</given-names></name><name><surname>Boone</surname><given-names>C</given-names></name><name><surname>Shilatifard</surname><given-names>A</given-names></name><name><surname>Buratowski</surname><given-names>S</given-names></name><name><surname>Greenblatt</surname><given-names>J</given-names></name></person-group><article-title>RNA polymerase II elongation factors of <italic>Saccharomyces cerevisiae</italic>: a targeted proteomics approach</article-title><source>Mol Cell Biol</source><year>2002</year><volume>22</volume><fpage>6979</fpage><lpage>6992</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.20.6979-6992.2002</pub-id><pub-id pub-id-type="pmid">12242279</pub-id></mixed-citation></ref><ref id="CR41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krogan</surname><given-names>NJ</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Tong</surname><given-names>A</given-names></name><name><surname>Golshani</surname><given-names>A</given-names></name><name><surname>Cagney</surname><given-names>G</given-names></name><name><surname>Canadien</surname><given-names>V</given-names></name><name><surname>Richards</surname><given-names>DP</given-names></name><name><surname>Beattie</surname><given-names>BK</given-names></name><name><surname>Emili</surname><given-names>A</given-names></name><name><surname>Boone</surname><given-names>C</given-names></name><name><surname>Shilatifard</surname><given-names>A</given-names></name><name><surname>Buratowski</surname><given-names>S</given-names></name><name><surname>Greenblatt</surname><given-names>J</given-names></name></person-group><article-title>Methylation of histone H3 by Set2 in <italic>Saccharomyces cerevisiae</italic> is linked to transcriptional elongation by RNA polymerase II</article-title><source>Mol Cell Biol</source><year>2003</year><volume>23</volume><fpage>4207</fpage><lpage>4218</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.12.4207-4218.2003</pub-id><pub-id pub-id-type="pmid">12773564</pub-id></mixed-citation></ref><ref id="CR42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunkel</surname><given-names>TA</given-names></name><name><surname>Roberts</surname><given-names>JD</given-names></name><name><surname>Zakour</surname><given-names>RA</given-names></name></person-group><article-title>Rapid and efficient site-specific mutagenesis without phenotypic selection</article-title><source>Methods Enzymol</source><year>1987</year><volume>154</volume><fpage>367</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1016/0076-6879(87)54085-X</pub-id><pub-id pub-id-type="pmid">3323813</pub-id></mixed-citation></ref><ref id="CR43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kushnirov</surname><given-names>VV</given-names></name></person-group><article-title>Rapid and reliable protein extraction from yeast</article-title><source>Yeast</source><year>2000</year><volume>16</volume><fpage>857</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1002/1097-0061(20000630)16:9&#x0003c;857::AID-YEA561&#x0003e;3.0.CO;2-B</pub-id><pub-id pub-id-type="pmid">10861908</pub-id></mixed-citation></ref><ref id="CR44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Masson</surname><given-names>I</given-names></name><name><surname>Yu</surname><given-names>DY</given-names></name><name><surname>Jensen</surname><given-names>K</given-names></name><name><surname>Chevalier</surname><given-names>A</given-names></name><name><surname>Courbeyrette</surname><given-names>R</given-names></name><name><surname>Boulard</surname><given-names>Y</given-names></name><name><surname>Smith</surname><given-names>MM</given-names></name><name><surname>Mann</surname><given-names>C</given-names></name></person-group><article-title>Yaf9, a novel NuA4 histone acetyltransferase subunit, is required for the cellular response to spindle stress in yeast</article-title><source>Mol Cell Biol</source><year>2003</year><volume>23</volume><fpage>6086</fpage><lpage>6102</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.17.6086-6102.2003</pub-id><pub-id pub-id-type="pmid">12917332</pub-id></mixed-citation></ref><ref id="CR45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majovski</surname><given-names>RC</given-names></name><name><surname>Khaperskyy</surname><given-names>DA</given-names></name><name><surname>Ghazy</surname><given-names>MA</given-names></name><name><surname>Ponticelli</surname><given-names>AS</given-names></name></person-group><article-title>A functional role for the switch 2 region of yeast RNA polymerase II in transcription start site utilization and abortive initiation</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>34917</fpage><lpage>34923</lpage><pub-id pub-id-type="doi">10.1074/jbc.M502932200</pub-id><pub-id pub-id-type="pmid">16081422</pub-id></mixed-citation></ref><ref id="CR46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malagon</surname><given-names>F</given-names></name><name><surname>Tong</surname><given-names>AH</given-names></name><name><surname>Shafer</surname><given-names>BK</given-names></name><name><surname>Strathern</surname><given-names>JN</given-names></name></person-group><article-title>Genetic interactions of DST1 in <italic>Saccharomyces cerevisiae</italic> suggest a role of TFIIS in the initiation&#x02013;elongation transition</article-title><source>Genetics</source><year>2004</year><volume>166</volume><fpage>1215</fpage><lpage>1227</lpage><pub-id pub-id-type="doi">10.1534/genetics.166.3.1215</pub-id><pub-id pub-id-type="pmid">15082542</pub-id></mixed-citation></ref><ref id="CR47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>E</given-names></name><name><surname>Ge</surname><given-names>H</given-names></name><name><surname>Tao</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>C</given-names></name><name><surname>Palhan</surname><given-names>V</given-names></name><name><surname>Roeder</surname><given-names>R</given-names></name></person-group><article-title>Novel cofactors and TFIIA mediate functional core promoter selectivity by the human TAFII150-containing TFIID complex</article-title><source>Mol Cell Biol</source><year>1998</year><volume>18</volume><fpage>6571</fpage><lpage>6583</lpage><pub-id pub-id-type="pmid">9774672</pub-id></mixed-citation></ref><ref id="CR48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizzen</surname><given-names>CA</given-names></name><name><surname>Yang</surname><given-names>XJ</given-names></name><name><surname>Kokubo</surname><given-names>T</given-names></name><name><surname>Brownell</surname><given-names>JE</given-names></name><name><surname>Bannister</surname><given-names>AJ</given-names></name><name><surname>Owen-Hughes</surname><given-names>T</given-names></name><name><surname>Workman</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Berger</surname><given-names>SL</given-names></name><name><surname>Kouzarides</surname><given-names>T</given-names></name><name><surname>Nakatani</surname><given-names>Y</given-names></name><name><surname>Allis</surname><given-names>CD</given-names></name></person-group><article-title>The TAF(II)250 subunit of TFIID has histone acetyltransferase activity</article-title><source>Cell</source><year>1996</year><volume>87</volume><fpage>1261</fpage><lpage>1270</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81821-8</pub-id><pub-id pub-id-type="pmid">8980232</pub-id></mixed-citation></ref><ref id="CR49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munnia</surname><given-names>A</given-names></name><name><surname>Schutz</surname><given-names>N</given-names></name><name><surname>Romeike</surname><given-names>BF</given-names></name><name><surname>Maldener</surname><given-names>E</given-names></name><name><surname>Glass</surname><given-names>B</given-names></name><name><surname>Maas</surname><given-names>R</given-names></name><name><surname>Nastainczyk</surname><given-names>W</given-names></name><name><surname>Feiden</surname><given-names>W</given-names></name><name><surname>Fischer</surname><given-names>U</given-names></name><name><surname>Meese</surname><given-names>E</given-names></name></person-group><article-title>Expression, cellular distribution and protein binding of the glioma amplified sequence (GAS41), a highly conserved putative transcription factor</article-title><source>Oncogene</source><year>2001</year><volume>20</volume><fpage>4853</fpage><lpage>4863</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1204650</pub-id><pub-id pub-id-type="pmid">11521196</pub-id></mixed-citation></ref><ref id="CR50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>LC</given-names></name><name><surname>Kornberg</surname><given-names>RD</given-names></name></person-group><article-title>Mediator of transcriptional regulation</article-title><source>Annu Rev Biochem</source><year>2000</year><volume>69</volume><fpage>729</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.69.1.729</pub-id><pub-id pub-id-type="pmid">10966474</pub-id></mixed-citation></ref><ref id="CR51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narlikar</surname><given-names>GJ</given-names></name><name><surname>Fan</surname><given-names>H-Y</given-names></name><name><surname>Kingston</surname><given-names>RE</given-names></name></person-group><article-title>Cooperation between complexes that regulate chromatin structure and transcription</article-title><source>Cell</source><year>2002</year><volume>108</volume><fpage>475</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(02)00654-2</pub-id><pub-id pub-id-type="pmid">11909519</pub-id></mixed-citation></ref><ref id="CR52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neely</surname><given-names>KE</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name></person-group><article-title>Histone acetylation and chromatin remodeling: which comes first?</article-title><source>Mol Genet Metab</source><year>2002</year><volume>76</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/S1096-7192(02)00014-8</pub-id><pub-id pub-id-type="pmid">12175774</pub-id></mixed-citation></ref><ref id="CR53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Roeder</surname><given-names>RG</given-names></name></person-group><article-title>GAS41 is required for repression of the p53 tumor suppressor pathway during normal cellular proliferation</article-title><source>Mol Cell Biol</source><year>2006</year><volume>26</volume><fpage>4006</fpage><lpage>4016</lpage><pub-id pub-id-type="doi">10.1128/MCB.02185-05</pub-id><pub-id pub-id-type="pmid">16705155</pub-id></mixed-citation></ref><ref id="CR54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>E</given-names></name><name><surname>Hur</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Kwon</surname><given-names>J</given-names></name></person-group><article-title>Mammalian SWI/SNF chromatin remodeling complexes are required to prevent apoptosis after DNA damage</article-title><source>DNA Repair (Amst)</source><year>2009</year><volume>8</volume><fpage>29</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2008.08.011</pub-id><pub-id pub-id-type="pmid">18822392</pub-id></mixed-citation></ref><ref id="CR55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parnell</surname><given-names>T</given-names></name><name><surname>Huff</surname><given-names>J</given-names></name><name><surname>Cairns</surname><given-names>B</given-names></name></person-group><article-title>RSC regulates nucleosome positioning at Pol II genes and density at Pol III genes</article-title><source>EMBO J</source><year>2008</year><volume>27</volume><fpage>100</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601946</pub-id><pub-id pub-id-type="pmid">18059476</pub-id></mixed-citation></ref><ref id="CR56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poon</surname><given-names>D</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Campbell</surname><given-names>AM</given-names></name><name><surname>Bjorklund</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Kornberg</surname><given-names>RD</given-names></name><name><surname>Weil</surname><given-names>PA</given-names></name></person-group><article-title>Identification and characterization of a TFIID-like multiprotein complex from <italic>Saccharomyces cerevisiae</italic></article-title><source>Proc Natl Acad Sci USA</source><year>1995</year><volume>92</volume><fpage>8224</fpage><lpage>8228</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.18.8224</pub-id><pub-id pub-id-type="pmid">7667272</pub-id></mixed-citation></ref><ref id="CR57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puig</surname><given-names>O</given-names></name><name><surname>Caspary</surname><given-names>F</given-names></name><name><surname>Rigaut</surname><given-names>G</given-names></name><name><surname>Rutz</surname><given-names>B</given-names></name><name><surname>Bouveret</surname><given-names>E</given-names></name><name><surname>Bragado-Nilsson</surname><given-names>E</given-names></name><name><surname>Wilm</surname><given-names>M</given-names></name><name><surname>Seraphin</surname><given-names>B</given-names></name></person-group><article-title>The tandem affinity purification (TAP) method: a general procedure of protein complex purification</article-title><source>Methods</source><year>2001</year><volume>24</volume><fpage>218</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1183</pub-id><pub-id pub-id-type="pmid">11403571</pub-id></mixed-citation></ref><ref id="CR58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert</surname><given-names>F</given-names></name><name><surname>Douziech</surname><given-names>M</given-names></name><name><surname>Forget</surname><given-names>D</given-names></name><name><surname>Egly</surname><given-names>JM</given-names></name><name><surname>Greenblatt</surname><given-names>J</given-names></name><name><surname>Burton</surname><given-names>ZF</given-names></name><name><surname>Coulombe</surname><given-names>B</given-names></name></person-group><article-title>Wrapping of promoter DNA around the RNA polymerase II initiation complex induced by TFIIF</article-title><source>Mol Cell</source><year>1998</year><volume>2</volume><fpage>341</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(00)80278-6</pub-id><pub-id pub-id-type="pmid">9774972</pub-id></mixed-citation></ref><ref id="CR59"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sambrook</surname><given-names>J</given-names></name><name><surname>Russell</surname><given-names>D</given-names></name></person-group><source>Molecular cloning: a laboratory manual</source><year>2001</year><publisher-loc>Cold Spring Harbor</publisher-loc><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name></mixed-citation></ref><ref id="CR60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawin</surname><given-names>K</given-names></name><name><surname>Tran</surname><given-names>P</given-names></name></person-group><article-title>Cytoplasmic microtubule organization in fission yeast</article-title><source>Yeast</source><year>2006</year><volume>23</volume><fpage>1001</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1002/yea.1404</pub-id><pub-id pub-id-type="pmid">17072892</pub-id></mixed-citation></ref><ref id="CR61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulze</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Kobor</surname><given-names>M</given-names></name></person-group><article-title>YEATS domain proteins: a diverse family with many links to chromatin modification and transcription</article-title><source>Biochem Cell Biol</source><year>2009</year><volume>87</volume><fpage>65</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1139/O08-111</pub-id><pub-id pub-id-type="pmid">19234524</pub-id></mixed-citation></ref><ref id="CR62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Mizuguchi</surname><given-names>G</given-names></name><name><surname>Hamiche</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name></person-group><article-title>A chromatin remodelling complex involved in transcription and DNA processing</article-title><source>Nature</source><year>2000</year><volume>406</volume><fpage>541</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1038/35020123</pub-id><pub-id pub-id-type="pmid">10952318</pub-id></mixed-citation></ref><ref id="CR63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Ranallo</surname><given-names>R</given-names></name><name><surname>Choi</surname><given-names>E</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name></person-group><article-title>Involvement of actin-related proteins in ATP-dependent chromatin remodeling</article-title><source>Mol Cell</source><year>2003</year><volume>12</volume><fpage>147</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(03)00264-8</pub-id><pub-id pub-id-type="pmid">12887900</pub-id></mixed-citation></ref><ref id="CR64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>H</given-names></name><name><surname>Ranallo</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>W-H</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name></person-group><article-title>Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates</article-title><source>Science</source><year>2003</year><volume>299</volume><fpage>112</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1126/science.1078068</pub-id><pub-id pub-id-type="pmid">12434013</pub-id></mixed-citation></ref><ref id="CR65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shia</surname><given-names>W-J</given-names></name><name><surname>Osada</surname><given-names>S</given-names></name><name><surname>Florens</surname><given-names>L</given-names></name><name><surname>Swanson</surname><given-names>SK</given-names></name><name><surname>Washburn</surname><given-names>MP</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name></person-group><article-title>Characterization of the yeast trimeric-SAS acetyltransferase complex</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>11987</fpage><lpage>11994</lpage><pub-id pub-id-type="doi">10.1074/jbc.M500276200</pub-id><pub-id pub-id-type="pmid">15659401</pub-id></mixed-citation></ref><ref id="CR66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sikorski</surname><given-names>RS</given-names></name><name><surname>Hieter</surname><given-names>P</given-names></name></person-group><article-title>A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in <italic>Saccharomyces cerevisiae</italic></article-title><source>Genetics</source><year>1989</year><volume>122</volume><fpage>19</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">2659436</pub-id></mixed-citation></ref><ref id="CR67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steger</surname><given-names>DJ</given-names></name><name><surname>Utley</surname><given-names>RT</given-names></name><name><surname>Grant</surname><given-names>PA</given-names></name><name><surname>John</surname><given-names>S</given-names></name><name><surname>Eberharter</surname><given-names>A</given-names></name><name><surname>Cote</surname><given-names>J</given-names></name><name><surname>Owen-Hughes</surname><given-names>T</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name></person-group><article-title>Regulation of transcription by multisubunit complexes that alter nucleosome structure</article-title><source>Cold Spring Harb Symp Quant Biol</source><year>1998</year><volume>63</volume><fpage>483</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1101/sqb.1998.63.483</pub-id><pub-id pub-id-type="pmid">10384312</pub-id></mixed-citation></ref><ref id="CR68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudarsanam</surname><given-names>P</given-names></name><name><surname>Winston</surname><given-names>F</given-names></name></person-group><article-title>The Swi/Snf family nucleosome-remodeling complexes and transcriptional control</article-title><source>Trends Genet</source><year>2000</year><volume>16</volume><fpage>345</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1016/S0168-9525(00)02060-6</pub-id><pub-id pub-id-type="pmid">10904263</pub-id></mixed-citation></ref><ref id="CR69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>A</given-names></name><name><surname>Shia</surname><given-names>WJ</given-names></name><name><surname>Band</surname><given-names>D</given-names></name><name><surname>Kaufman</surname><given-names>PD</given-names></name><name><surname>Osada</surname><given-names>S</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name><name><surname>Sternglanz</surname><given-names>R</given-names></name></person-group><article-title>Sas4 and Sas5 are required for the histone acetyltransferase activity of Sas2 in the SAS complex</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>16887</fpage><lpage>16892</lpage><pub-id pub-id-type="doi">10.1074/jbc.M210709200</pub-id><pub-id pub-id-type="pmid">12626510</pub-id></mixed-citation></ref><ref id="CR70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tansey</surname><given-names>WP</given-names></name><name><surname>Herr</surname><given-names>W</given-names></name></person-group><article-title>TAFs: guilt by association?</article-title><source>Cell</source><year>1997</year><volume>88</volume><fpage>729</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81916-9</pub-id><pub-id pub-id-type="pmid">9118213</pub-id></mixed-citation></ref><ref id="CR71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullem</surname><given-names>V</given-names></name><name><surname>Wery</surname><given-names>M</given-names></name><name><surname>Bolle</surname><given-names>X</given-names></name><name><surname>Vandenhaute</surname><given-names>J</given-names></name></person-group><article-title>Construction of a set of <italic>Saccharomyces cerevisiae</italic> vectors designed for recombinational cloning</article-title><source>Yeast</source><year>2003</year><volume>20</volume><fpage>739</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1002/yea.999</pub-id><pub-id pub-id-type="pmid">12794935</pub-id></mixed-citation></ref><ref id="CR72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>SS</given-names></name><name><surname>Shen</surname><given-names>WC</given-names></name><name><surname>Reese</surname><given-names>JC</given-names></name><name><surname>Apone</surname><given-names>LM</given-names></name><name><surname>Green</surname><given-names>MR</given-names></name></person-group><article-title>Yeast TAF(II)145 required for transcription of G1/S cyclin genes and regulated by the cellular growth state</article-title><source>Cell</source><year>1997</year><volume>90</volume><fpage>607</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80522-X</pub-id><pub-id pub-id-type="pmid">9288741</pub-id></mixed-citation></ref><ref id="CR73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>AY</given-names></name><name><surname>Schulze</surname><given-names>JM</given-names></name><name><surname>Skordalakes</surname><given-names>E</given-names></name><name><surname>Gin</surname><given-names>JW</given-names></name><name><surname>Berger</surname><given-names>JM</given-names></name><name><surname>Rine</surname><given-names>J</given-names></name><name><surname>Kobor</surname><given-names>MS</given-names></name></person-group><article-title>Asf1-like structure of the conserved Yaf9 YEATS domain and role in H2A.Z deposition and acetylation</article-title><source>PNAS</source><year>2009</year><volume>106</volume><issue>51</issue><fpage>21573</fpage><lpage>21578</lpage><pub-id pub-id-type="doi">10.1073/pnas.0906539106</pub-id><pub-id pub-id-type="pmid">19966225</pub-id></mixed-citation></ref><ref id="CR74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>MD</given-names></name><name><surname>Drubin</surname><given-names>DG</given-names></name></person-group><article-title>A nuclear protein with sequence similarity to proteins implicated in human acute leukemias is important for cellular morphogenesis and actin cytoskeletal function in <italic>Saccharomyces cerevisiae</italic></article-title><source>Mol Biol Cell</source><year>1994</year><volume>5</volume><fpage>617</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">7949419</pub-id></mixed-citation></ref><ref id="CR75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>MD</given-names></name><name><surname>Vinh</surname><given-names>DB</given-names></name><name><surname>Okamura</surname><given-names>HH</given-names></name><name><surname>Drubin</surname><given-names>DG</given-names></name></person-group><article-title>Screens for extragenic mutations that fail to complement act1 alleles identify genes that are important for actin function in <italic>Saccharomyces cerevisiae</italic></article-title><source>Genetics</source><year>1993</year><volume>135</volume><fpage>265</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">8243992</pub-id></mixed-citation></ref><ref id="CR76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Hirota</surname><given-names>K</given-names></name><name><surname>Mizuno</surname><given-names>K</given-names></name><name><surname>Shibata</surname><given-names>T</given-names></name><name><surname>Ohta</surname><given-names>K</given-names></name></person-group><article-title>Essential roles of Snf21, a Swi2/Snf2 family chromatin remodeler, in fission yeast mitosis</article-title><source>Genes Genet Syst</source><year>2008</year><volume>83</volume><fpage>361</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1266/ggs.83.361</pub-id><pub-id pub-id-type="pmid">19168987</pub-id></mixed-citation></ref><ref id="CR77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Richardson</surname><given-names>DO</given-names></name><name><surname>Roberts</surname><given-names>DN</given-names></name><name><surname>Utley</surname><given-names>R</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name><name><surname>Tempst</surname><given-names>P</given-names></name><name><surname>Cote</surname><given-names>J</given-names></name><name><surname>Cairns</surname><given-names>BR</given-names></name></person-group><article-title>The Yaf9 component of the SWR1 and NuA4 complexes is required for proper gene expression, histone H4 acetylation, and Htz1 replacement near telomeres</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>9424</fpage><lpage>9436</lpage><pub-id pub-id-type="doi">10.1128/MCB.24.21.9424-9436.2004</pub-id><pub-id pub-id-type="pmid">15485911</pub-id></mixed-citation></ref><ref id="CR78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zobeck</surname><given-names>KL</given-names></name><name><surname>Burton</surname><given-names>ZF</given-names></name></person-group><article-title>Human RNA polymerase II elongation in slow motion: role of the TFIIF RAP74 alpha1 helix in nucleoside triphosphate-driven translocation</article-title><source>Mol Cell Biol</source><year>2005</year><volume>25</volume><fpage>3583</fpage><lpage>3595</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.9.3583-3595.2005</pub-id><pub-id pub-id-type="pmid">15831464</pub-id></mixed-citation></ref><ref id="CR79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziegler</surname><given-names>LM</given-names></name><name><surname>Khaperskyy</surname><given-names>DA</given-names></name><name><surname>Ammerman</surname><given-names>ML</given-names></name><name><surname>Ponticelli</surname><given-names>AS</given-names></name></person-group><article-title>Yeast RNA polymerase II lacking the Rpb9 subunit is impaired for interaction with transcription factor IIF</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>48950</fpage><lpage>48956</lpage><pub-id pub-id-type="doi">10.1074/jbc.M309656200</pub-id><pub-id pub-id-type="pmid">14522989</pub-id></mixed-citation></ref></ref-list></back></article>